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ABSTRACT 
 Choline oxidase from Arthrobacter globiformis is a flavin-dependent enzyme that 
catalyzes the oxidation of choline to betaine aldehyde through two sequential hydride-transfer 
steps.  The study of this enzyme is of importance to the understanding of glycine betaine 
biosynthesis found in pathogenic bacterial or economic relevant crop plants as a response to 
temperature and salt stress in adverse environment.  In this study, chemical modification of 
choline oxidase using two irreversible inhibitors, tetranitromethane and phenylhydrazine, was 
performed in order to gain insights into the active site structure of the enzyme.  Choline oxidase 
can also be inactivated irreversibly by freezing in 20 mM sodium phosphate and 20 mM sodium 
pyrophosphate at pH 6 and -20 oC.  The results showed that enzyme inactivation was due to a 
localized conformational change associated with the ionization of a group in close proximity to 
the flavin cofactor and led to a complete lost of catalytic activity. 
 
INDEX WORDS: Choline Oxidase, Flavoproteins, Enzyme Inactivation, Chemical 
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Chapter I 
INTRODUCTION 
 
1.  Previous Studies of Choline Oxidase 
 1.1. Early studies.  In 1937, an active form of choline oxidase was first isolated from rat 
liver and kidney by Bernheim and Bernheim (1).  The enzyme was capable of oxidizing choline 
to betaine aldehyde with the uptake of one and two moles of oxygen at pH 6.7 and 7.8, 
respectively.  Subsequent work by Mann et al. reported a more detailed study on the same 
enzyme (2).  In that study, choline oxidase was considered as a typical dehydrogenase due to the 
fact that rat liver extracts could reduce sodium ferricyanide rapidly under anaerobic conditions.  
Kinetic studies showed evidence of this enzyme oxidizing choline and arsenocholine, and 
oxygen uptake was observed corresponding to the formation of aldehyde species.  The oxidation 
of choline and arsenocholine by choline oxidase was inhibited by ammonium ions, 
trimethylammonium ions, and betaine, suggesting that the trimethylammonium headgroup is 
important for the binding of the ligand to the enzyme.  Since choline dehydrogenase, in the 
presence of choline and arsencholine, reduced cytochrome c at room temperature without the 
help of enzyme cofactors, it was proposed that the choline oxidase system was composed of 
choline dehydrogenase, cytochrome c, and cytochrome oxidase.  
 Choline oxidase from Arthrobacter globiformis was first purified by Ikuta et al. in 1977 
(3).  The purification procedure involved fractionations with ammonium sulfate and acetone, 
followed by column chromatography using the anionic exchanger DEAE-cellulose and gel 
filtration through a Sephadex G-200 column.  The molecular mass of the isolated enzyme was 
between 71 kDa and 83 kDa, as suggested by SDS-PAGE and gel filtration, respectively.  UV-
visible absorbance spectra of the enzyme showed maxima at 363 and 450 nm, consistent with the 
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spectroscopic properties of a flavoenzyme.  Kinetic data indicated that choline oxidase is capable 
of utilizing both choline and betaine aldehyde as substrates to produce glycine betaine with Km 
values of 1.2 mM and 8.7 mM, respectively.  In addition, the enzymatic activity decreased 
significantly when a number of substrate analogs were used, suggesting high substrate specificity 
of the enzyme toward choline and betaine aldehyde.  During the catalytic reaction of choline 
oxidase, formation of hydrogen peroxide was detected as equivalent to the amount of oxygen 
being consumed.  Based on these data, the authors proposed a mechanism for the catalytic 
reaction by choline oxidase, which involved the oxidation of choline to glycine betaine with 
betaine aldehyde as the intermediate and molecular oxygen as the electron acceptor (Scheme 1.1) 
(3, 4). 
 
N+ OH
H2O2
O2
N+ H
H2O2
N+ O
OH2O, O2O
CH3
CH3
H3C
CH3
CH3
H3C
CH3
CH3
H3C
 
Scheme 1.1.  Reaction catalyzed by choline oxidase. 
 
 1.2. Prosthetic group of choline oxidase.  In 1979, the prosthetic group of choline 
oxidase from A. globiformis was studied in detail by digesting the enzyme into peptide fragments 
with trypsin and chymotrypsin (5).  The peptides were purified to reveal a fragment with a 
typical UV-visible absorbance spectrum of a flavin.  The flavin species in choline oxidase was 
identified as FAD rather than FMN due to the fact that the flavin fluorescence intensity increased 
by 2-fold upon release of AMP after the hydrolysis of the enzyme with nucleotide 
pyrophosphatase.  When the fluorescence excitation spectrum of the flavin peptide from choline 
oxidase was compared with that of free riboflavin, a 25 nm hypsochromic shift of the 346 nm 
peak to 361 nm was observed for the aminoacyl flavin.  This suggested that the flavin cofactor 
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was covalently attached to the enzyme via the 8α-methylene group of its isoalloxazine ring.  In 
order to determine whether the flavin is bound to N(1) or N(3) position of the histidyl ring, 
sodium borohydride was used to reduce flavin.  This was done because the N(1) isomer of 
histidyl flavin could be reduced in the presence of borohydride, as followed by the quenching of 
flavin fluorescence, whereas the N(3) isomer cannot be reduced (6).  The purified flavin peptide 
of choline oxidase was not reduced by sodium borohydride, suggesting that the flavin cofactor 
was bound to the N(3) position of the histidine residue.  A subsequent study by Ohta-Fukuyama 
et. al. on choline oxidase from Alcaligens sp. confirmed 8α-[N(3)-histidyl]-FAD as the prosthetic 
group of the enzyme, as suggested by the electrophoretic mobility of the hydrolysate of the 
methylated histidylflavin (7).  In that study, the flavin was bound to the enzyme with a 1:1 ratio 
to give a spectrum with 358 nm and 453 nm maxima and a shoulder at 480 nm.  The covalently 
bound FAD in the native enzyme could be reduced with choline or betaine aldehyde under 
anaerobic conditions and re-oxidized when exposed to air. 
 The spectroscopic properties of choline oxidase from Alcaligens sp. were investigated 
thoroughly by Ohta et al. to provide an in depth understanding of the properties of the covalently 
bound flavin (8).  Upon reduction of the enzyme using dithionite or photo-irradiation in the 
presence of EDTA, formation of flavin semiquinone was observed.  This semiquinone was 
catalytically inert towards organic substrate and oxygen.  The insensitivity of the flavin 
semiquinone toward oxygen makes choline oxidase unique because such feature was not found 
among other flavoenzymes.  Choline oxidase could form a complex with glycine betaine, the 
product of its catalytic reaction, with a dissociation constant of 17 mM at pH 7.5.  When the 
enzyme-product complex was reduced with dithionite or photo-irradiation under anaerobic 
conditions, no semiquinone formation was detected.  The reduced form of enzyme-product 
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reacted with oxygen and reoxidized at two different rates: rapid and slow.  The authors proposed 
the formations of two different flavin species in the photoreaction of the enzyme-product 
complex: a C4a adduct that reacted slowly with oxygen, and an N5 adduct that reacted quickly 
with oxygen. 
 In a recent study, Rand et al. investigated the flavin linkage in choline oxidase from A. 
globiformis (9). In that study, a purified histidylriboflavin was treated with NaBH4 in order to 
distinguish between the N(1) and N(3) isomers.  Treatment of NaBH4 stemmed from the fact that 
flavin fluorescence of N(1)-histidylriboflavin can be irreversibly quenched upon reduction with 
NaBH4, whereas N(3)-histidylriboflavin is unreactive toward NaBH4 (10).  N(1) and N(3) 
isomers can also be distinguished by their stability in aqueous solution at room temperature: N(1) 
is stable under these conditions but N(3) can be decomposed to 8-formylriboflavin (11).  These 
results, along with the pKa value from the pH-dependent fluorescence of the histidylriboflavin, 
indicated an N(1)-linked flavin.  The position of the histidine residue to which the flavin is 
covalently bound was also examined by subjecting choline oxidase to tryptic cleavage.  The 
FAD-containing peptide was isolated using HPLC and analyzed with mass spectrometry.  The 
flavin-containing peptide was found to be the tripeptide His-Ala-Arg at position 87-89 based on 
the nucleotide sequence of codA gene, which has been previously reported in Genbank 
(accession number X84895) for choline oxidase from A. globiformis (12).  The authors 
concluded that choline oxidase contains 8-[N(1)-histidyl]flavin at position 87 in its polypeptide 
chain.1  
                                                 
1 Sequencing analysis of the cloned choline oxidase by our group in 2004 showed that the 
nucleotide sequence of codA gene previously reported in Genbank in 2003 by Rand et al. (12) 
contained seven flaws, resulting in a translated protein with significantly altered amino acid 
sequence between position 298 and 410.  Consequently, the results obtained based on that 
sequence might not be accurate. 
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 1.3. Biotechnological and medical applications. In the past decade, the biotechnological 
and medical applications of choline oxidase have been studied extensively.   This was motivated 
by the finding that glycine betaine accumulated in the cytoplasm of cells as a resistance for 
adverse environments with low and high temperature or hyperosmotic stress (13, 14).  For plants 
that do not synthesize glycine betaine, such as Arabidopsis thaliana, transformation of betaine-
synthesizing gene (codA gene from A. globiformis) into the plant cells significantly increased the 
survival of the plants in high-salt soils (up to 300 mM NaCl) (15) or at freezing temperatures 
(16).   Over the years, many studies have been conducted in order to use the protective function 
of glycine betaine to improve the economic production of crop plants, such as tomato (17), rice 
(18, 19), and tobacco (20).  In all cases, the presence of glycine betaine showed a significant 
increase in cold and salt stress tolerance in growing plants.  Accumulation of glycine betaine has 
also been observed in human pathogens, such as Staphylocccus aureus (21), Pseudomonas 
aeruginosa (22), and Listeria monocytogenes (23), in resistance to high osmolarities and 
unsuitable thermal conditions.  S. aureus is a bacterium commonly found on the skin of a healthy 
person; it can cause illnesses ranging from minor skin infections to fatal diseases such as 
pneumonia, meningitis, endocarditis and septicemia (13).  L. monocytogenes is a food-born 
pathogen that causes food poisoning and infections in digestive tracts (21, 23).   P. aeruginosa 
can cause a variety of systemic infections, such as dermatitis, bacteremia, urinary tract 
infections, respiratory system infections, soft tissue infections, bone and joint infections, and 
gastrointestinal infections.  For these reasons, understanding the mechanism of the biosynthesis 
of glycine betaine has the potential for the developments of therapeutic agents that can inhibit the 
growth of these pathogens in the host tissue.   
  
6
 1.4. Cloning and expression of choline oxidase.   As the interest for understanding the 
biosynthesis of glycine betaine in choline oxidase grew, large quantities of the enzyme were 
needed for biophysical, mechanistic, and structural investigations.   In a recent study by our 
group, the codA gene for choline oxidase was cloned from genomic DNA of A. globiformis strain 
ATCC 8010 and expressed in the E. coli strain Rosetta(DE3)pLysS (24).  The enzyme was 
purified using DEAE-Sepharose column and characterized using mass spectrometry.  The 
resulting enzyme contained a mixture of the anionic semiquinone and oxidized forms of FAD.  
The oxidized form of choline oxidase was obtained after 24 h of dialysis at pH 6 and 4 oC.  Gel 
filtration and mass spectrometry indicated that the enzyme was a homodimer with covalently 
bound flavin and a molecular mass of 120 kDa.  Enzyme assay with choline and betaine 
aldehyde showed that the enzyme was active and used both as substrates.  A newly amino acid 
sequence was obtained for choline oxidase, showing a greater similarity between choline oxidase 
and the members in GMC oxidoreductase superfamily than the sequence originally reported in 
GeneBank (9).  (See last paragraph in Section 1.2 for more detail) 
1.5. Spectroscopic properties of choline oxidase.  In another study, the spectroscopic 
properties of recombinant choline oxidase with its cofactor in the oxidized and semiquinone 
forms were characterized (25).  The UV-visible absorbance spectrum of the oxidized enzyme 
showed two typical flavin peaks at 359 and 452 nm, with an extinction coefficient at 452 nm of 
11.4 mM-1 cm-1 at pH 8.  This enzyme form emitted light at 530 nm when being excited at 452 
nm.  Upon incubation with dithionite under aerobic conditions, the peak at 452 nm in UV-visible 
absorbance spectrum was bleached to give rise to a new spectrum with maxima at 372 and 495 
nm.  This spectrum remained unchanged after gel filtration was used to remove excess dithionite, 
suggesting that choline oxidase stabilized the anionic semiquinone species of the flavin in the 
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presence of oxygen.  Consistent with this observation, the maxima of the flavin UV-visible 
absorbance spectrum returned to 350 and 452 nm when the enzyme was unfolded with 4 M urea.  
The circular dichroic spectrum of the enzyme-bound semiquinone showed a sharp negative peak 
at 406 nm and a broad negative peak from 450 to 650 nm, which was in agreement with the 
previously reported circular dichroic properties of enzyme-bound anionic flavin semiquinones 
(7, 26).  The anionic flavin semiquinone in choline oxidase was converted to its oxidized form 
with kobs of 219 x 10-6 s-1 when the enzyme was incubated at pH 6 and 15 oC.  The evidence for 
this came from the bleaching of the 372 nm peak to give rise to a 452 nm peak in the UV-visible 
absorbance spectrum.  A similar bleaching of the 452 nm peak followed by an increase in 
absorbance at 320 nm was also observed when the enzyme was treated with sodium sulfite, an 
indication of the formation of a covalent N(5)-flavin adduct.  The enzyme bound  sulfite with a 
Kd value of ~50 µM at pH 7 and 15 oC; such high affinity suggested the presence of a positive 
charge near the N(1)C(2)=O locus of the flavin.  UV-visible absorbance and steady state kinetics 
were used to monitor the enzyme turnover with either choline or betaine aldehyde.  The results 
showed that the flavin semiquinone remained spectroscopically and kinetically insensitive to the 
substrates and therefore did not participate in catalysis.  The pH dependence of the kinetic 
parameters was determined for both choline and oxygen using enzyme with oxidized flavin and 
enzyme containing a mixture of oxidized and semiquinone flavins.  The data indicated the 
presence of a catalytic base with a pKa of ~ 7.5 that was required for the oxidation of the 
substrate but not for the reduction of oxygen.  In agreement with this observation, an ionizable 
group with the same pKa value was required to be protonated for product inhibition, suggesting 
that this ionizable group might belong to the same amino acid that acted as the catalytic base in 
the oxidation of substrate. 
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1.6. Kinetic properties of choline oxidase.  The kinetic mechanism of commercially 
available choline oxidase from A. globiformis was studied in detail using either choline or 
betaine aldehyde as substrate (27).  At pH 7, the steady state kinetic mechanism of the enzyme 
was determined to be sequential.  The reduced enzyme was found to react with oxygen before 
the second oxidation step or before the release of the product.  Based on the kinetic pattern of 
1/rate versus 1/[O2], a Km value of ≤20 µM was estimated for betaine aldehyde as substrate, 
consistent with betaine aldehyde preferentially  partitioning forward to catalysis rather than 
dissociating from the enzyme (28).  This conclusion was further supported by the observation 
that ≤10% betaine aldehyde was found in the reaction mixture under enzymatic turnover with 
saturating concentrations of choline.  The kcat for betaine aldehyde was two times higher than the 
value observed with choline, suggesting that the oxidation of choline to the aldehyde 
intermediate may be partially rate-limiting for catalysis.  The results obtained from this study led 
to a proposed mechanism for the reaction catalyzed by choline oxidase, which involved two 
sequential flavin-linked hydride transfers from choline and the resulting betaine aldehyde 
intermediate to molecular oxygen. 
In a subsequent study, pH and deuterium kinetic isotope effects were used to examine the 
oxidation of choline to betaine aldehyde (29).  At atmospheric oxygen, the kcat and kcat/Km values 
of choline oxidase increased with increasing pH to limiting values, suggesting the presence of a 
catalytic base in catalysis.  When choline was used as substrate in a pH-dependent study, an 
apparent pKa of 7.5 was determined for the catalytic base.  This pKa shifted to 8.0 when choline 
was substituted with [1,2-2H4]-choline, suggesting a significant commitment to catalysis.  The 
D(kcat/Km) determined in atmospheric oxygen decreased from a limiting value of 12.4 at low pH 
  
9
to a limiting value of 4.1 at high pH, consistent with the cleavage of C-H bond of choline being 
fully rate-limiting at low pH. 
1.7. Mechanistic studies.  To determine the substrate recognition and specificity of 
choline oxidase, choline and glycine betaine analogs were used as substrates and inhibitors, 
respectively (30).  As shown in Table 1, the competitive inhibition constant (Kis) decreased with 
increasing number of methyl groups on the substrate.  In contrast, replacement of the acetate 
moiety of glycine betaine with neutral groups, such as methyl, ethyl, allyl, and 2-aminoethyl, did 
not affect the binding of the ligand to the enzyme.  This was suggested by the lack of changes in 
the Kis value.  These data indicated that the trimethylammonium moiety is important for substrate 
recognition and specificity, but the acetate moiety is not.  Additional evidence supporting the 
importance of the trimethylammonium head group of the ligand was found when N,N-
dimethylethanolamine and N-methylethanol were used as substrate analogs for choline.  Steady 
state kinetic data showed that the enzyme was capable of utilizing these compounds as substrate 
but with a significant decrease in the kcat and kcat/Km values (Table 2).  When 3,3-dimethyl-butan-
1-ol was used as substrate, kcat and kcat/Km values decreased 10 times as compared to those with 
choline as substrate.  This suggested that the positive charge at the trimethylammonium head 
group was also important for substrate binding. 
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Table 1.1.  Inhibition studies of choline oxidase at pH 6.5a 
Inhibitor Structure Kis, mM R2 
Glycine betaine 
COO-N
CH3
CH3
H3C
 
15 ± 2 0.984 
N,N-Dimethylglycine 
COO-N
CH3
H
H3C
 
57 ± 1 0.995 
N-Methylglycine 
COO-N
H
H
H3C
 
405 ± 2 0.998 
Tetramethylamine 
N
CH3
CH3
H3C CH3
 
11 ± 1 0.997 
Trimethylamine 
N
CH3
CH3
H3C H
 
2.4 ± 0.2 0.998 
Trimethylethylamine 
N
CH3
CH3
H3C C2H5
 
13 ± 2 0.988 
Allyltrimethylamine 
N
CH3
CH3
H3C
 
15 ± 1 0.999 
2-Amino-trimethylethylamine 
N
CH3
CH3
H3C NH3
 
9 ± 1b 0.993 
aCholine oxidase activity was measured at varying concentrations of both 
choline and inhibitor in air-saturated 50 mM sodium pyrophosphate, pH 
6.5 and 25 oC, modified from Ref (30). bValue determined for the 
protonated form of 2-amino-trimethylethylamine. 
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Table 1.2.  Steady state kinetic parameters for choline and N-substituted choline analogs as 
substrates for choline oxidase at pH 8a 
Substrate Structure kcat, s-1 kcat/Kmc, M-1s-1 R2 
Choline N
CH3
CH3
H3C OH
 
86 ± 1 200,000 ± 10,000 0.995 
N,N-Dimethylethanolamine N
CH3
H
H3C OH
 
  5.9 ± 0.1 18,400 ± 300 0.996 
N-Methylethanolamine N
CH3
H
H
OH
 
  0.37 ± 0.01    710 ± 10 0.994 
3,3-Dimethyl-1-butanol C
CH3
CH3
H3C OH
 
  8.0 ± 0.1   7,900 ± 980 0.980 
aCholine oxidase activity was measured at varying concentrations of organic substrate and oxygen 
in 50 mM sodium pyrophosphate, pH 8, and 25 oC, data from Ref. (30). bkcat/Km is the kcat/Km value 
for the organic substrate. 
 
A subsequent study using pH and solvent viscosity effects with 3,3-dimethyl-butan-1-ol, 
the isosteric analog of choline, was carried out to support the importance of the positive charge 
on the trimethylammonium headgroup to substrate binding in choline oxidase (31).  The pH-
dependent study of kcat and kcat/Km values of choline oxidase with 3,3-dimethyl-butan-1-ol 
yielded pKa values that are comparable to the pKa values previously determined for choline 
oxidase with choline as a substrate.  However, the limiting values of the pH profiles for kcat and 
kcat/Km were ~3 and ~400 times lower than those with choline, suggesting a significant decrease 
in the efficiency of catalytic reaction.  This is consistent with kcat/Km for oxygen when 3,3-
dimethyl-butan-1-ol was used as substrate being independent with a limiting value that was ~75 
times lower than when choline was used.  Solvent viscosity effects were used to examine 
whether the kinetics steps of substrate binding limit the rate of substrate oxidation steps.  As a 
result, there was no viscosity effects observed for both kcat and kcat/Km, consistent with the 
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chemical steps in substrate oxidation being fully rate-limiting for the overall turnover of the 
enzyme with 3,3-dimethyl-butan-1-ol as substrate.  Overall, the data presented in this study 
agreed with previous proposed roles for the positive charge head group on choline being 
essential for substrate binding and flavin oxidation. 
Recently, an in-depth study of the catalytic steps in the reaction catalyzed by the 
recombinant choline oxidase was carried out in our laboratory using steady state and pre-steady 
state kinetics approaches under saturating oxygen (32).  In that study, substrate and solvent 
isotope effects were used to probe the status of the substrate OH and CH bond cleavage.  The 
results indicated that the reductive half-reaction that involves the cleavage of the substrate CH 
bond was not masked by other kinetic steps, as suggested by the pH independent value of ~10.6 
for D(kcat/Km) and a Dkred value of 8.9 at pH 10 for the anaerobic reduction of the bound-flavin by 
choline in both protio and deuterated solvents.  At pH 10, no solvent kinetic isotope effect was 
observed for kcat/Km and kcat, and Dkcat and D2Okcat values were 7.3 and 1.1, respectively.  These 
results indicated that the removal of the substrate hydroxyl proton and the hydride transfer from 
the substrate occur in a stepwise fashion with the formation of a transient alkoxide intermediate 
species.  Overall, the data from both steady state and pre-steady state kinetics provided evidence 
for the chemical steps of the substrate oxidation by choline oxidase being fully rate-limiting for 
both the overall turnover and the reductive half reaction involving the oxidation of choline to 
betaine aldehyde. 
The first oxidation step in the reaction catalyzed by choline oxidase was further 
characterized by varying oxygen concentrations and temperature in the studies of the kinetic 
isotope effects with deuterated choline (33).  The Dkcat and D(kcat/Km) values were pH–
independent at saturating oxygen concentrations, but at ≤0.97 mM oxygen, these values 
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decreased at high pH to a limiting value.  The same pattern was observed for kcat and kcat/Km 
when choline was used as substrate at oxygen concentrations ≤0.25 mM.  These data suggested 
that at high concentrations of oxygen, the partition forward to catalysis of the reduced form of 
enzyme-betaine aldehyde complex was more favored than its reverse partition to the oxidized 
enzyme-choline alkoxide species. When temperature was varied under saturating oxygen 
concentrations, D(kcat/Km) was 10.6 ± 0.6 and temperature independent.  The isotope effect on the 
preexponential factor was determined to be 14 ± 3, which was too large for the classical over-the 
barrier behavior for hydride transfer, whose preexponential factor was predicted to be between 
0.7 and 1.7.  In addition, similar enthalpies of activation, ∆H‡, were determined for choline and 
1,2-[2H4]-choline, suggesting the cleavage of CH and CD bond did not follow the theoretical 
model of H and D tunneling, which happen just below the transistion state.  That is because this 
model suggests that the lack of temperature dependence in the kinetic isotope effect is associated 
with the lack of temperature dependence of the reaction rates with both H and D (34).  In this 
study, the similarities in preexponential factor values of kcat/Km and Dkcat/Km as well as in ∆H‡ for 
kcat/Km values with choline and 1,2-[2H4]-choline implied that the tunneling of the hydride 
observed for the case of choline oxidase may occurs quantum mechanically in a highly 
preorganized active site, in which environmental vibrations shorten the distance between the 
donor and the acceptor of the hydride allowing a more efficient hydride transfer (34-36).  
The mechanism of oxidation of betaine aldehyde was also studied by using spectroscopic 
and kinetic methods (37), in which the steady state and pre-steady state kinetics of choline 
oxidase with betaine aldehyde and its analogue 3,3-dimethylbutyraldehyde were examined.  (It 
should be noted that 3,3-dimethylbutyraldehyde has the similar chemical structure as betaine 
aldehyde but without the positive charge at the trimethylammonium head group [Figure 1.1]). 
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3,3-dimethylbutyraldehydebetaine aldehyde
CH3
NH3C
CH3
H
O
CH3
NH3C
CH3
H
O
 
Figure 1.1.  Chemical structures of betaine aldehyde and 3,3-dimethylbutyraldehyde. 
 
At saturating oxygen, the pH dependence of the kinetic parameters for betaine aldehyde 
suggested that a catalytic base with a pKa value of ~6.7 was required for the oxidation of betaine 
aldehyde.  Under anaerobic conditions, choline oxidase was completely reduced in the presence 
of choline or betaine aldehyde at pH 8 with a kred value of ≥48 s-1.  However, only 10-26% of the 
enzyme was reduced in the presence of 3,3-dimethylbutyraldehyde between pH 6 and 10.  
Competitive inhibition was observed when enzyme activity was assayed with choline in the 
presence of 3,3-dimethylbutyraldehyde.  NMR spectroscopic analysis revealed that 99% of 
betaine aldehyde exists in its hydrated form in aqueous solution, while 3,3-
dimethylbutyraldehyde exists predominantly in its nonhydrated form.  The reason that hydrated 
form of betaine aldehyde is more favored stems from the stabilization of the hydroxyl group by 
the positive charge at the trimethylammonium head group.  In related work, kinetic data with 
NAD+-dependent yeast aldehyde dehydrogenase indicated that the keto species of 3,3-
dimethylbutyraldehyde was reactive toward enzymic nucleophiles.  The data in this study 
suggested that betaine aldehyde was required to be in its hydrated form for the oxidation to 
glycine betaine.  This was proposed to be a catalytic strategy that allowed choline oxidase to 
catalyze two sequential oxidation reactions of an alcohol and an aldehyde within the same active 
site and minimize the amount of energy spent for similar catalytic strategies. 
In a search for the catalytic base of choline oxidase, His466 was substituted by both 
alanine and asparatate (38, 39).  The choice of mutation at His466 site in choline oxidase 
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stemmed from previous studies of other enzymes that catalyze the oxidation of alcohol 
substrates.  Based on the studies of cholesterol oxidase (40, 41), cellobiose dehydrogenase (42), 
and glucose oxidase (43, 44), a histidine is fully conserved within the active site of the enzyme 
family, corresponding to His466 in choline oxidase, and this residue might act as the catalytic 
base in the oxidation of alcohol substrates.  If His466 were the catalytic base in the reaction, the 
enzyme would be expected to be completely devoid of activity upon replacing His466 with an 
alanine.  However, the kinetic data for the His466Ala mutant indicated otherwise (38).  The 
enzyme was still active with this mutation, but the kcat and kcat/Km for choline as substrate at 
atmospheric oxygen decreased 60- and 1000-fold, respectively, as compared to the wild type 
enzyme.  In contrast, the kcat/Km for oxygen was unaffected, suggesting the involvement of 
His466 in the oxidation of choline but not in the reduction of oxygen.  The UV-visible 
absorbance spectrum of His466Ala mutant as purified contained the oxidized form of the flavin, 
whereas wild type choline oxidase as purified contained a mixture of oxidized flavin and its 
anionic semiquinone (24, 25).  Treatment of the His466Ala mutant with dithionite under aerobic 
conditions at pH 8 resulted in the formation of the anionic flavin semiquinone, which was rapidly 
returned to its oxidized form upon removal of excess dithionite by gel filtration.  These data 
indicated that upon replacing His466 with an alanine, the enzyme lost its ability to stabilize the 
semiquinone form of flavin in the presence of oxygen.  When the mutant protein was incubated 
with 25 or 100 mM sodium sulfite for 3.5 h at pH 6.5, no change in the absorbance spectrum was 
detected.  This was another difference from the established spectroscopic properties of the wild 
type enzyme, suggesting that the microenvironment of the flavin was significantly altered upon 
mutating His466.  This conclusion was also supported by the fact that the midpoint reduction 
potential of two-electron transfer in the catalytically competent-enzyme substrate complex at pH 
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7 was ~25 mV more negative than wild type enzyme.  In the presence of the protonated 
imidazole, the enzyme activity was partially rescued.  In contrast, the neutral imidazole had no 
effect.  These data indicated that His466 in wild type enzyme was protonated.  Both the pH-
profiles of product inhibition and of kcat/Km of choline showed an upward shift of pKa, consistent 
with a change in polarity of the active site of the enzyme.  The relative timing of OH and CH 
bond cleavage in substrate oxidation was also affected when His466 was replaced with alanine, 
as suggested by the data from deuterium, solvent, and multiple kinetic effects.  Overall, the data 
ruled out the hypothesis of His466 that was the catalytic base in the reaction catalyzed by choline 
oxidase.  However, the positive charge contributed by the His466 is critical for stabilizing the 
negative charges in the enzyme active site that found on the N(1) position of the flavin and on 
the hydroxyl group of the substrate.   
In another study, His466 was replaced with an asparatate (His466Asp) (39).  With the 
reversal of charge in the active site, the enzyme was completely devoid of activity, as indicated 
by the lack of oxygen consumption and no bleaching of the 452 nm absorbance peak under 
anaerobic conditions in the presence of 10 mM choline.  However, the enzyme was still capable 
of binding the substrate because there was a 4 nm bathochromic shift of the 452 nm peak that 
was associated with an increase in absorbance at 375 nm in the UV-visible absorbance spectrum 
of the flavin in H466D mutant.  A Kd of 0.45 ± 0.04 mM was determined for the binding affinity 
of the mutant protein for choline by monitoring the spectral changes with increasing 
concentrations of choline.  In contrast, the enzyme had lost its ability to bind glycine betaine 
because there was no spectral change with increasing concentration of this ligand.  The mutation 
also caused 75% of the flavin to be uncovalently bound in choline oxidase.  Anaerobic reduction 
of the enzyme-bound flavin in His466Asp using xanthine and xanthine oxidase at pH 6 resulted 
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in the formation of neutral hydroquinone, with no stabilization of the semiquinone intermediate.  
The data presented in this study indicated that upon replacing a positive charge with a negative 
charge near the N(1) locus of the flavin in choline oxidase, the enzyme has lost its ability to 
stabilize the negative charges in the active site, which might lead to defective flavinylation of the 
protein and change in eletrophilicity of the flavin, therefore resulting in loss of enzymatic 
activity. 
 1.8. Summary.  Based on the available data, a detailed mechanism for the reaction 
catalyzed by choline oxidase was proposed.  The enzyme catalyzes the oxidation of choline to 
glycine betaine through two sequential flavin-linked hydride transfers with molecular oxygen as 
the final electron acceptor and betaine aldehyde as the intermediate.  In the first oxidation step 
(Scheme 1.2), choline is converted into its alkoxide form by an active site base with pKa of ~7.5.  
A hydride is transferred from the α-carbon of choline to the enzyme-bound flavin cofactor via 
tunneling pathway.  Consequently, the flavin is reduced and betaine aldehyde is formed as the 
intermediate.  In order to re-oxidize the cofactor for the next oxidation step, the enzyme uses an 
oxygen molecule as the electron acceptor, resulting in the formation of hydrogen peroxide.  
Betaine aldehyde is hydrated before the next hydride transfer step.  The second hydride transfer 
happens when the active site base abstract a proton from the gem-diol species of aldehyde, 
resulting in another CH bond cleavage and the formation of a carboxylate product, glycine 
betaine.  The flavin is reduced by accepting the hydride from betaine aldehyde and reoxidized by 
transferring two electrons to an oxygen molecule.  The turnover cycle of choline oxidase is 
completed when the product is released from the active site as the flavin becomes oxidized.  
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Scheme 1.2.  The catalytic cycle of choline oxidase.  Illustrated based on previous studies of choline oxidase. 
 
  
19
2. Phenylhydrazine as a Mechanism-based Inhibitor 
Hydrazine compounds have been studied extensively as mechanism-based inhibitors of a 
wide variety of proteins, including heme-containing proteins such as horseradish peroxidase 
(45), lactoperoxidase (46), hemoglobin (47), myoglobin (47), cytochrome P-450 (48), catalase 
(49), flavoproteins such as monoamine oxidase (50) and trimethylamine dehydrogenase (51), and 
copper proteins such as dopamine β–hydroxylase (52) and plasma amine oxidase (53).  The 
inhibition mechanisms of the enzymes with hydrazines were studied in detail for a few cases, in 
which enzyme inactivation usually involved the generation of a carbon-centered radical or anion 
at the active site (49, 51).  These species were highly unstable and could react with the cofactors 
or active site residues in the enzyme.  For this reason, hydrazines were used in many chemical 
modification studies with the aim of identifying important residues in the active site.  Among 
many hydrazines, phenylhydrazine was commonly used as one of the inhibitors of mitochondrial 
monoamine oxidase, an enzyme found in the central nervous system that can breakdown 
monoamine neurotransmitters (54).     
2.1. In flavoenzymes.  Approaches for investigation the inhibition effects of 
phenylhydrazine can be illustrated by studies of monoamine oxidase (50, 55) and trimethylamine 
dehydrogenase (51, 56).  Monoamine oxidase is a flavoenzyme that catalyzes the oxidative 
deamination of neurologically active amines, e.g., serotonin.  Early studies showed that 
hydrazines competed with the amine substrate for the enzyme active site (57-60).  Inactivation of 
the enzyme was proposed to involve oxidative processes (61-63) because maximal inhibition 
could be achieved only in the presence of oxygen (64).  Patek and Hellerman later conducted a 
more detailed study on the inactivation of monoamine oxidase by phenylhydrazine (50).  The 
inactivation was shown to be complete and irreversible in the presence of oxygen.  Under 
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anaerobic conditions, the flavin cofactor was reduced by phenylhydrazine but could be 
reoxidized when exposed to air to give an 80% recovery of enzyme activity.  This observation 
suggested the oxidation of the hydrazine inhibitor occurred before enzyme inactivation.  A 
Hammett study, in which the effects of nuclear substitution on the phenylhydrazine were 
correlated with the rates of hydrazine-induced inhibition, suggested that flavin reduction by 
phenylhydrazine was rate-limiting in the overall aerobic inhibition process.  Spectroscopic data 
showed that progressive incubation of the enzyme with phenylhydrazine under aerobic 
conditions could cause an irreversible bleaching of the flavin peak.  When inactive enzyme was 
digested with trypsin, spectral analysis of the peptide containing the flavin cofactor gave 
evidence for the formation of a flavin adduct.  The intermediate phenyldiazene formed after the 
oxidation of phenylhydrazine was thought to be responsible for the irreversible modification of 
flavin cofactor. 
 The inhibitory mechanism of trimethylamine dehydrogenase with hydrazines has also 
been studied.  Trimethylamine dehydrogenase has several properties in common with 
mammalian monoamine oxidase, including covalently-bound flavin (65) and similar responses to 
a variety of monoamine oxidase inhibitors (66).  In work by Nagy et al. (51), the oxidation of 
phenylhydrazine to the intermediate phenyldiazene was observed under aerobic and anaerobic 
conditions.  After the flavin peak at 454 nm was bleached upon incubation with phenylhydrazine, 
a flavin species at 360 nm was seen.  This flavin species was isolated by proteolytic digestion 
and analyzed using mass spectrometry.  Upon comparison with model compounds, the modified 
flavin was identified as an arylated flavin.  Generally, absorbance at 360 nm is indicative for 
flavin modification at either the C(4a) or the N(5) position (67).  The two sites of modification 
are distinguished by the fact that N(5) flavin adducts are shifted ~30 nm hypsochromatically in 6 
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M HCl, whereas C(4a) adducts are shifted ~30 nm in the opposite direction (67).  The spectral 
properties of the arylated flavin showed that C(4a) was the position of modification (Figure 1.1). 
N
N
N
N O
O
X
H
Y
Z
H
H3C
H3C
 
Figure 1.2.  Structure of flavin C(4a) adduct.  X, Y, and Z represent the side chains on flavin 
cofactor. 
 
The authors also investigated the reaction of phenylhydrazine and its intermediate phenyldiazene 
with free flavin.  Due to the photosensitivity of free flavin, the experiments were performed in 
the dark.  Phenylhydrazine seemed to react slowly with the flavin, while phenyldiazene reacted 
rapidly to form the C(4a) adduct.  This observation supported the dehydrogenation of 
phenyhydrazine by the enzyme being a rate-limiting step in the inhibitory mechanism. 
2.2. In copper enzymes.  The irreversible inactivation by hydrazine inhibitors was also 
found in copper enzymes.  In a study by Fitzpatrick (52), dopamine β-hydroxylase was 
inactivated with different hydrazines for the purpose of identifying the active site residues 
around the copper cofactor.  Several hydrazines were tested, including phenyl-, phenethyl-, 
benzyl-, and methylhydrazine, and hydrazine itself.  Enzyme inactivation was observed with 
phenyl-, phenethyl-, benzyl-, and methylhydrazine, but not with hydrazine.  The most rapid 
inactivation was observed with phenylhydrazine.  When the effect of different substrates of 
dopamine β-hydroxylase upon the inactivation rate was tested, the hydrazines were divided into 
two distinguishable classes.  With phenyl-, phenethyl-, and methylhydrazine as inhibitors, the 
oxidation of copper was required for the inactivation to occur, as suggested by the slower 
inactivation rate in the presence of the reductant ascorbate.  In contrast, the inactivation with 
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benzylhydrazine required the enzyme in its reduced form, as suggested by the faster inactivation 
rate in the presence of ascorbate. The substrate tyramine also had different effects on the rate of 
inactivation when the same inhibitors were used: the inactivation rate decreased with 
benzylhydrazine, increased with phenylhydrazine and methylhydrazine, but remained unchanged 
with phenethylhydrazine.  In the presence of both tyramine and ascorbate, the inactivation rate 
decreased in both cases; therefore, the enzyme inactivation might occur at the active site.  Such 
observations were consistent with the proposed inhibitory mechanisms for monoamine oxidase 
and trimethylamine dehydrogenase discussed above in that the inactivation of the enzyme by 
hydrazine inhibitors involved the reduction of the enzyme cofactor.  To directly test the ability of 
the enzyme to generate radicals from hydrazines, the α-(-4-pyridyl-1-oxide)-N-tert-butylnitrone 
(PORN) spin trap was employed to trap the carbon-centered radicals that formed in the reaction.  
PORN was a reversible inhibitor of dopamine β-hydroxylase, and therefore had already bound to 
the active site of the enzyme before the radicals were generated, resulting in the trapping of 
various carbon-centered radicals.  Analysis of the PORN-adduct in this study showed that the 
inhibitory mechanism by monosubstituted hydrazines involved a generation of a hydrazine 
cation radical, followed by the cleavage of the carbon-nitrogen bond to form a carbon-centered 
radical and diazene (Scheme 1.2). 
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Scheme 1.3.  Proposed inhibitory mechanism of dopamine β-hydroxylase by monosubstituted 
hydrazines.  Illustration based on the descriptions in ref (52). 
 
The generation of a carbon-centered radical from the decomposition of phenylhydrazine radical 
cation was observed in this study.  Based on HPLC analysis, the stoichiometry of labeling of the 
enzyme was 1 phenylhydrazine per subunit.  This was consistent with the presence of one copper 
in the active site of each monomer.  Kinetic isotope effects were also used to gain insights into 
the catalytic path.  When the benzylic hydrogens of benzylhydrazine were replaced with 
deuterium, an isotope effect of ~13 was observed for Vmax, and the partition ratio for product 
formation vs. inactivation decreased up to 11-fold.  Therefore, the authors proposed that the 
inactivation of the enzyme was due to abstraction of an electron from nitrogen instead of 
abstraction of a hydrogen atom from the benzylic carbon. 
2.3. In heme containing enzymes. The mechanism of inhibition by phenylhydrazine has 
been studied for heme containing enzymes such as lacrimal-gland peroxidase (LGP) (68).  LGP 
is found in the secretion of the lacrimal gland and has the ability to prevent oxidative damage 
and bacterial infection (69).  The oxidation of various substrates including halides, 
pseudohalides, aromatic electron donors and xenobiotics is catalyzed by this enzyme.  In a study 
by Mazumdar et al. (68), LGP was inactivated irreversibly by the mechanism-based inhibitor 
phenylhydrazine in the presence of H2O2.  The enzyme could be protected from the inactivation 
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in the presence of the electron donor SCN- and the free-radical trap 5,5-dimethyl-1-pyrroline N-
oxide (DMPO).  The experiments with DMPO suggested the involvement of a radical species in 
the inactivation process.  Earlier studies with myoglobin (70, 71), hemoglobin (72, 73), catalase 
(49), and cytochrome P-450 (48) showed the formation of a stable iron-phenyl complex in the 
interaction of phenylhydrazine with the enzyme.  The Soret shift in circular dichroic spectra was 
used as one of the lines of evidence for the existence of an iron-phenyl complex in the inactive 
enzyme.  In the case of LPG, there was no shift in the Soret region upon treatment with 
phenylhydrazine.  Instead, a significant loss of absorbance intensity at 409 nm and the 
appearance of a negative ellipticity at 275 nm were observed.  The far-UV circular dichroic 
spectra of the native and modified enzymes were indistinguishable, ruling out inactivation due to 
a gross structural change upon reaction of radicals with amino acid residues.  The authors 
proposed that the heme iron might be buried deep inside the enzyme where it was inaccessible to 
the radicals, and the inactivation involved the modification of heme environment.  A kinetic 
study of LPG inactivation showed a stoichiometry of 2:1 of H2O2/phenylhydrazine.  Therefore, 
phenylhydrazine was oxidized through one-electron transfer to phenyl radicals, which bound to 
the vicinity of the heme group, prevented electron transfer from the donor residue to the heme 
ferryl group, and led to enzyme inactivation.   
 
3. Tetranitromethane (TNM) as an Irreversible Inhibitor 
  Tetranitromethane (TNM) has been used in chemical modification of many proteins since 
1930 (74).  In many cases, incubation with this reagent resulted in the irreversible inactivation of 
the enzyme.  Detailed studies of the chemical modification using TNM have suggested that TNM 
is specific for tyrosyl residues (75, 76).  The reaction of TNM with tyrosine involves the 
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formation of a charge-transfer complex with the phenol group of the amino acid, followed by the 
generation of the phenoxide and nitrite radicals due to electron transfer.  Nitration occurs when 
phenoxide and nitrite radicals react, resulting in the release of a nitroformate anion (Scheme 1.4).  
Additional reactions are possible due to the high reactivity of phenolate radicals with each other.   
TNM
C(NO2)
3-
OH
HO
O
NH2
OH
HO
O
NH2 NO2
 
Scheme 1.4.  Nitration of tyrosyl residue by tetranitromethane. 
 
TNM can also oxidize sufhydryl groups under the same conditions (77).  In a study by 
Sokolovsky et al. (77), disulfide and nitrite ions were generated in the presence of excess thiol.  
Hydrolysis of the intermediate sulfenyl nitrate resulted in the formation of sulfinic acid as the 
product.  The ratio of sulfinic acid to disulfide formation depended on the conditions of the 
reaction and the nature of the R group on the thiol compounds.  A significant extent of other side 
reactions is also observed for the reaction of enzymes with TNM.  However, unwanted reactions 
can be distinguished by lowering the pH because under acid conditions, i.e. pH ≤6, nitration of 
tyrosine does not occur, whereas the modification is rapid at pH ≥9.  
Despite the fact that the reaction of enzymes with TNM involves many side reactions, the 
reagent has been used successfully in identifying active site tyrosines.  The most common 
problem is usually the poor solubility of TNM in water.  Therefore, ethanol is usually used to 
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prepare the TNM stock solutions.  The amount of TNM used to modify the enzyme is 
consequently limited to 10% or less ethanol in the reaction mixture to prevent denaturation of the 
enzyme by excess ethanol.  Chemical modification using TNM is readily quantitated because 
nitrotyrosine absorbs at 360 nm (Figure 1.3) (78). 
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Figure 1.3.  Typical spectra of a TNM-modified enzyme.  Spectra obtained from the study on 
chemical modification of choline oxidase with TNM, which described in details in Chapter V. 
 
In a study by Gadda et al. (79), TNM was used for the modification of the flavoprotein 
nitroalkane oxidase.  Nitroalkane oxidase catalyzes the oxidation of nitroalkanes to aldehydes or 
ketones with nitrite and hydrogen peroxide as the products.  Upon incubation with TNM at pH 
7.5, the enzyme was irreversibly inactivated.  The rate of inactivation as a function of TNM 
concentration followed saturation kinetics, suggesting that the inhibitor bound to the enzyme 
prior to inactivation.  In the presence of the catalytic product of the nitroalkane oxidase reaction, 
the enzyme was protected from inactivation.   This indicated that the nitration reaction occurred 
at the active site of the enzyme.  The UV-visible absorbance spectrum of the inactive enzyme 
showed a significant perturbation in absorbance wavelength as compared to the active enzyme.  
Comparison of tryptic maps of the treated and untreated enzymes followed by mass 
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spectrometric analysis revealed a modified tyrosine at position 82.  Based on earlier studies of 
flavoenzymes such as D-amino acid oxidase (81), flavocytochrome b2 (82), p-hydroxybenzoate 
hydroxylate (83), and glucose oxidase (84), a conserved tyrosine residue in the active site of 
these enzymes is found to participate in binding the carboxylate moiety of the substrate.  Because 
the structure of carboxylate group is similar to that of the nitro group, the authors proposed that 
this tyrosine might also be essential for binding the substrate in nitroalkane oxidase. 
 
4. Effects of Freezing on Enzymes in Storage 
For years, research laboratories routinely stored enzymes in frozen solutions because it is 
believed that the long-term stability of enzymes in frozen solution is greater than in unfrozen 
solutions.  However, in some cases, freezing and thawing may cause substantial enzyme 
denaturation, which can be detected as alterations of the enzyme structure or loss of catalytic 
activity.  The low temperature perse and pH-shift of the solution as it cools (85, 86) usually 
viewed as the main causes of enzyme denaturation in frozen storage.  For this reason, freezing 
can induce reversible inactivation of pH-sensitive enzymes. 
4.1. pH-shift in storage buffers.  Although buffers are often used to store enzymes in 
order to maintain constant pH, evidences for pH shift upon freezing due to precipitation of the 
less-soluble buffer component have been well documented.  For Tris, citrate, and potassium 
phosphate, the pH has been reported to change up to +1, -0.4, and +0.6 unit, respectively, upon 
freezing (87, 88).  The most dramatic pH changes have been observed with disodium phosphate 
(Na2HPO4.12H2O) (85, 86) up to 3.5 pH units.  In work by Pikal-Cleland et al., protein 
                                                 
2 With the crystal structure of the nitroalkane oxidase obtained just recently by Nagpal et al. (80), 
the tyrosine that has been identified in the study by Gadda et al. (79) was proposed to be at 
position 398. 
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denaturation during freezing and thawing in potassium phosphate (KP) and sodium phosphate 
(NaP) buffer was studied (86).  Tetrameric β-galactosidase was chosen in this study because its 
inactivation can be monitored with large structural changes from tetramer to monomer.  In 
addition, earlier studies indicated that this protein lost activity when its subunits dissociated at 
pH ≤ 6 (89, 90); the pH optimum for protein stability is between 6 and 8 (91, 92).  In that study, 
the pH changes during freezing were determined under nonequilibrium conditions.  A combined 
pH electrode was used with a reference solution containing potassium chloride, glycerol, and 
formaldehyde that kept the electrolyte solution from freezing and enabled pH measurements 
down to -30 oC.  When the enzyme was stored at -10 oC in 100 mM or 10 mM NaP with initial 
pH of 7.0, the pH significantly decreased to 3.8 or 5.5, respectively.  In contrast, when the 
enzyme was stored in 100 mM or 10 mM KP at -10 oC and pH 7, the pH of the frozen solutions 
were 7.3 and 7.1, respectively.  The magnitude of pH shifting in both buffers was dependent on 
buffer concentrations with higher concentrations giving salt crystallization upon freezing.  In the 
ice-liquid interphase, water formed ice crystals and escaped from the buffer phase, resulting in a 
more solute-concentrated buffer.  The precipitation of buffer salts can happen at different times 
and at various temperatures, depending on their solubility and buffer concentrations (93, 94).  Ice 
crystals usually form before the precipitation of buffer salts.  These crystals pull the basic 
phosphate species (i. e., HPO42-) away from the solution, thereby inducing a pH shift due to the 
change in the ratio of base to acid in the buffer.  In the case with NaP and KP buffers, disodium 
salt is much less soluble in water than potassium salt because their eutectic points are -0.5 oC and 
-13.7 oC, respectively.  Therefore, the HPO42- species of NaP buffer was depleted from solution 
much earlier than that of KP buffer leading to a greater change in pH.  For β-galactosidase, the 
lower recovery of activity and larger structural alterations was observed after freezing and 
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thawing in NaP buffer than in KP buffer.  This was used as evidence for the larger pH shift of 
NaP.  The effects of the freezing and thawing rates on activity recovery of the enzyme were also 
investigated using different cooling and warming methods.  Data on activity recovery and 
infrared spectroscopy of the enzyme structure revealed that less enzyme was denatured when fast 
cooling and fast warming methods were used.  This implied that rapid freezing and thawing can 
minimize the time of exposure of the enzyme to low pH and high salt concentrations, thereby 
resulting in less denaturation of enzyme from storage.   
 4.2. Reversible inactivation of enzymes. In limited cases, freezing can induce reversible 
inactivation of pH-sensitive enzymes; this has been observed in the case of L-amino acid oxidase 
(LAAO) from Crotalus adamanteus (95).  LAAO is a snake venom enzyme that catalyzes a 
flavin-dependent reaction involving the oxidative deamination of a number of L-amino acids.  In 
that study, the enzyme was stored in 0.2 M Tris-HCl, pH 7.8, and frozen at temperatures between 
-5 to -60 oC.  The maximal inactivation was observed when the enzyme was stored at -20 oC, as 
suggested by the dramatic loss of enzymatic activity.  Repeated freezing and thawing did not 
affect the rate of inactivation.  No inactivation was observed in the absence of freezing.  The 
degree of inactivation was directly dependent on Tris-HCl buffer concentrations between 2 mM 
to 200 mM, but was independent of enzyme concentrations in storage.  Under anaerobic 
conditions, a protective effect against freezing inactivation was observed in the presence of 
substrates, such as L-leucine and L-arginine.  However, there was no protection when the 
enzyme was reduced anaerobically with dithionite.  Glycerol and dimethyl sulfoxide also 
protected the enzyme.  This was explained with the hypothesis that glycerol and methylsulfoxide 
influenced the ice structure in a way that prevented the formation of the inactive form of the 
enzyme.  Spectroscopic data from protein fluorescence showed that the inactive enzyme 
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maintained its native conformation.  UV-visible absorbance spectra of the enzyme-bound FAD 
cofactor showed the inactivation of the enzyme was associated with 7 nm and 12 nm 
hypsochromic shifts of the 462 nm and 390 nm peaks, respectively.  Photoreduction in the 
presence of EDTA was used to examine the reduction properties of the FAD in the inactive 
enzyme.  The rate of the reduction was 10-fold lower than that of active enzyme and only 50% of 
flavin semiquinone could be formed.  Based on spectroscopic and photoreduction data, the 
authors concluded that the microenvironment of the flavin in the inactive form of the enzyme 
was significantly affected.  The reactivation process of LAAO was also investigated.  The 
enzyme was fully reactivated at pH 5 by increasing the temperature.  Adjustment of the pH to 5 
or an increase in temperature alone could not reactivate the enzyme; both were required for a full 
reactivation of LAAO.  When the UV-visible absorbance of FAD was monitored during the 
reactivation process, the absorbance spectrum eventually became similar to that of the native 
enzyme, which further supported the conclusion that the inactivation of the enzyme was 
associated with changes in the flavin microenvironment.  The temperature-dependence of 
reactivation yielded a ∆H‡ of 36 to 41 kcal mol-1 (151 to 171 kJ mol-1).  These large ∆H‡ values 
from temperature reactivation were in conflict with spectroscopic data, which showed no large 
protein conformational change.  The authors explained the effect of temperature on freezing 
inactivation using the following model: 
Eact E* Ein
k
 
where Eact and Ein represent the active and inactive forms of enzyme, E* represents a metastable 
form of enzyme that is in equilibrium with Eact, and k represents the rate constant for the 
conversion from E* to Ein.  E* was produced as a result of ice formation, therefore 
Eact E* had large ∆H‡.  The rate of inactivation, k, was governed by a small ∆H‡ if the 
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conversion from E* Ein  involved only a few breakages of chemical interactions.  For 
these reasons, the maximal inactivation was observed at the midpoint temperature, i. e. -20 oC, 
due to high concentration of E* and the rate of inactivation was still significant.   When the 
enzyme was stored at -2 oC, no significant inactivation was observed because there was not 
enough E*.  At -60 oC, most of the enzyme was in the E* form and k had become so low that the 
inactivation was not detectable anymore. 
 The freezing-inactivation study by Curti et al. was done early before the pH shift in 
storage buffers was investigated extensively.  However, the authors also tested the effect of 
different buffers on the inactivation of LAAO during freezing.  Lower inactivation rates were 
observed when sodium or potassium phosphate was used as buffers instead of Tris.  The authors 
proposed that phosphates protected the enzyme from freezing inactivation. 
  
5. Hysteretic Behavior in Enzymes 
 5.1. General description of hysteretic behavior in enzymes.  The term “hysteresis” came 
from physics and was defined as a slow response that was exhibited by a body in reacting to 
outside forces.  Hysteretic behavior of enzyme, on the other hand, was defined as a slow 
response to a change in ligand concentrations (96).  Such behavior was observed most often in 
regulatory enzymes as kinetic cooperativity; however, there have been reports of hysteretic 
enzymes found in other classes, such as ovoperoxidase (97) and leucocyte proteinase (98).   
 In the 1970s, extensive studies on hysteretic enzymes were carried out by Frieden (96, 
99).  In his studies, two mechanisms were believed to be responsible for the slow response in 
enzymes: 1) isomerization processes and 2) displacement of a tightly bound ligand by another 
with a different effect on activity.  Isomerization processes usually involved conformational 
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changes in the enzyme that were slow relative to the rate of the reaction (96).  Generally, the 
rates of conformational change in enzymes are so fast as compared to the rate of the catalytic 
reaction that they are difficult to detect.  However, it is possible to have multiple local 
conformational changes that occur one after another causing a delay in enzymatic activity.  
Displacement reactions involved the dissociation of the ligand from the enzyme (96).  In the 
presence of two different ligands, i.e., enzyme inhibitor and substrate, the activity of the enzyme 
increased upon the displacement of the inhibitor by the substrate at a rate that depended on how 
rapidly the inhibitor is released from the enzyme surface.  Therefore, the longer the inhibitor 
bound, the longer the lag in enzymatic activity. 
 5.2. Analysis of hysteretic behavior.  The analysis of hysteric behavior in enzymes is 
fairly complicated because the rate of product accumulation or substrate depletion in activity 
assays occurs following single exponential function (99).  Frieden approached the problem by 
introducing an equation that describes a burst or lag in product appearance (or substrate 
consumption), which is followed by a linear accumulation of product: 
kt
t vvvv
−−+= )e( fif    (1) 
where vt is the velocity as a function of time, vf is the velocity after the burst or lag, vi is the 
initial velocity, and k the observed rate for the transition of one form to another form of enzyme.  
This equation is applicable to hysteretic mechanisms with the assumption that the kinetic 
measurements are performed in the absence of substrate depletion or product accumulation.  
However, such assumption may affect the evaluation of k if k is dependent on substrate or 
enzyme concentrations. 
 Frieden’s study on hysteretic behavior of the enzymes extended to detailed analysis of 
different enzyme systems.  The more complicated the system, the more difficult the analysis.  
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Therefore, it should be noted that the summary provided herein only included a portion of the 
hysteresis theory that is applicable for the purpose of the study presented in this thesis.  For a 
more detailed treatment of this topic, the reader is referred to Ref. (96, 99). 
 
6. Goals 
The oxidation of choline to glycine betaine is catalyzed by choline oxidase through two 
sequential flavin-linked hydride transfers with molecular oxygen as the final electron acceptor 
and betaine aldehyde as the intermediate.  The study of this enzyme is of importance for medical 
and biotechnological applications because the product of its catalytic reaction, glycine betaine, is 
a compatible solute that is accumulated in many pathogenic bacteria (100-109), and transgenic 
plants (12, 16, 18, 20, 110, 111) in response to adverse hyperosmotic environment (13, 14). 
Therefore, the study of choline oxidase has the potential for the development of therapeutic 
agents that target the biosynthesis of glycine betaine in human pathogenic bacteria, and for the 
engineering of drought and salt stress resistance in beneficial bacteria and crop plants.  For this 
reason, the aim of the research presented herein is to investigate the mechanism of enzyme 
inactivation through mechanism-based inhibition and storage conditions. 
To understand the active site structure of choline oxidase is extremely important for the 
mechanistic study of an enzyme.  In this regard, chemical modification of choline oxidase is an 
effective tool for identifying the active site residues that are essential to catalysis.  Active site 
modifications require the use of irreversible mechanism-based inhibitors as labels.  
Consequently, the first step in this study was to search for an irreversible inhibitor for choline 
oxidase using compounds with understood inhibitory mechanisms.  Phenylhydrazine and 
tetranitromethane were found to inactivate choline oxidase to significant extends, so the kinetics 
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of inactivation and the structural properties of the inactive enzyme were carefully studied in this 
research. 
During the procedure employed to purify choline oxidase, choline oxidase showed a 
significant hysteretic behavior after storing at pH 6 and -20 oC (Fan Fan, Prashanthi Menon, Jane 
V. Hoang, and Giovanni Gadda; unpublished observations), a step used to fully oxidize the 
enzyme-bound flavin (30), suggesting that the enzyme might be affected by freezing at low pH.  
Since such freezing effects have rarely been reported for enzyme in storage, investigation on the 
effect of storage temperature and pH on the biophysical and catalytic properties of choline 
oxidase can give insights into such phenomenon.  In addition, storing purified enzymes in frozen 
solution was almost always employed in our laboratory.  Therefore, to understand the inhibitory 
mechanism of choline oxidase by freezing can help choosing the appropriate conditions for 
enzymes in storage. 
 
References 
(1) Bernheim, F., and Bernheim, M. L. C. (1937) The choline oxidase of liver. Am. J. 
Physiol. 121, 55-60. 
(2) Mann, P. J. G., Woodward, H. E., and Quastel, J. H. (1938) Hepatic oxidation of choline 
and arsenocholine. Biochem. J. 32, 1024-32. 
(3) Ikuta, S., Imamura, S., Misaki, H., and Horiuti, Y. (1977) Purification and 
characterization of choline oxidase from Arthrobacter globiformis. J. Biochem. (Tokyo) 
82, 1741-9. 
(4) Ikuta, S., Matuura, K., Imamura, S., Misaki, H., and Horiuti, Y. (1977) Oxidative 
pathway of choline to betaine in the soluble fraction prepared from Arthrobacter 
globiformis. J. Biochem. (Tokyo) 82, 157-63. 
(5) Ohishi, N., and Yagi, K. (1979) Covalently bound flavin as prosthetic group of choline 
oxidase. Biochem. Biophys. Res. Commun. 86, 1084-8. 
  
35
(6) Edmondson, D. E., Kenney, W. C., and Singer, T. P. (1976) Structural elucidation and 
properties of 8α-(N1-histidyl)riboflavin: the flavin component of thiamine 
dehydrogenase and beta-cyclopiazonate oxidocyclase. Biochemistry 15, 2937-45. 
(7) Ohta-Fukuyama, M., Miyake, Y., Emi, S., and Yamano, T. (1980) Identification and 
properties of the prosthetic group of choline oxidase from Alcaligenes sp. J. Biochem. 
(Tokyo) 88, 197-203. 
(8) Ohta, M., Miura, R., Yamano, T., and Miyake, Y. (1983) Spectroscopic studies on the 
photoreaction of choline oxidase, a flavoprotein, with covalently bound flavin. J. 
Biochem. (Tokyo) 94, 879-92. 
(9) Rand, T., Halkier, T., and Hansen, O. C. (2003) Structural characterization and mapping 
of the covalently linked FAD cofactor in choline oxidase from Arthrobacter globiformis. 
Biochemistry 42, 7188-94. 
(10) Edmondson, D. E., and De Francesco, R. (1992) Chemistry and biochemistry of 
flavoenzymes,  (Muller, F., Ed.) pp 73-103, CRC Press, Boca Raton. 
(11) Edmondson, D. E. (1974) Intramolecular hemiacetal formation in 8-formylriboflavine. 
Biochemistry 13, 2817-21. 
(12) Deshnium, P., Los, D. A., Hayashi, H., Mustardy, L., and Murata, N. (1995) 
Transformation of Synechococcus with a gene for choline oxidase enhances tolerance to 
salt stress. Plant. Mol. Biol. 29, 897-907. 
(13) McNeil, S. D., Nuccio, M. L., and Hanson, A. D. (1999) Betaines and related 
osmoprotectants. Targets for metabolic engineering of stress resistance. Plant Physiol. 
120, 945-50. 
(14) Burg, M. B., Kwon, E. D., and Kultz, D. (1997) Regulation of gene expression by 
hypertonicity. Annu. Rev. Physiol. 59, 437-55. 
(15) Hayashi, H., Alia, Mustardy, L., Deshnium, P., Ida, M., and Murata, N. (1997) 
Transformation of Arabidopsis thaliana with the codA gene for choline oxidase; 
accumulation of glycinebetaine and enhanced tolerance to salt and cold stress. Plant J. 
12, 133-42. 
  
36
(16) Sakamoto, A., Valverde, R., Alia, Chen, T. H., and Murata, N. (2000) Transformation of 
Arabidopsis with the codA gene for choline oxidase enhances freezing tolerance of 
plants. Plant J. 22, 449-53. 
(17) Park, E. J., Jeknic, Z., Sakamoto, A., DeNoma, J., Yuwansiri, R., Murata, N., and Chen, 
T. H. (2004) Genetic engineering of glycine betaine synthesis into tomato protects seeds, 
plants, and flowers from chiling damage. Plant J. 40, 474-87. 
(18) Sakamoto, A., Alia, Murata, N., and Murata, A. (1998) Metabolic engineering of rice 
leading to biosynthesis of glycinebetaine and tolerance to salt and cold. Plant Mol. Biol. 
38, 1011-9. 
(19) Mohanty, A., Kathuria, H., Ferjani, A., Sakamoto, A., Mohanty, P., Murata, N., and 
Tyagi, A. K. (2002) Transgenics of an elite indica rice variety Pusa Basmati 1 harbouring 
the codA gene are highly tolerant to salt stress. Theor. Appl. Genet. 106, 51-7. 
(20) Holmström, K. O., Somersalo, S., Mandal, A., Palva, T. E., and Welin, B. (2000) 
Improved tolerance to salinity and low temperature in transgenic tobacco producing 
glycine betaine. J. Exp. Bot. 51, 177-85. 
(21) Landfald, B., and Strom, A. R. (1986) Choline-glycine betaine pathway confers a high 
level of osmotic tolerance in Escherichia coli. J. Bacteriol. 165, 849-55. 
(22) Tsuge, H., Nakano, Y., Onishi, H., Futamura, Y., and Ohashi, K. (1980) A novel 
purification and some properties of rat liver mitochondrial choline dehydrogenase. 
Biochim. Biophys. Acta. 614, 274-84. 
(23) Sleator, R. D., Wouters, J., Gahan, C. G., Abee, T., and Hill, C. (2001) Analysis of the 
role of OpuC, an osmolyte transport system, in salt tolerance and virulence potential of 
Listeria monocytogenes. Appl. Environ. Microbiol. 67, 2692-8. 
(24) Fan, F., Ghanem, M., and Gadda, G. (2004) Cloning, sequence analysis, and purification 
of choline oxidase from Arthrobacter globiformis: a bacterial enzyme involved in 
osmotic stress tolerance. Arch. Biochem. Biophys. 421, 149-158. 
(25) Ghanem, M., Fan, F., Francis, K., and Gadda, G. (2003) Spectroscopic and kinetic 
properties of recombinant choline oxidase from Arthrobacter globiformis. Biochemistry 
42, 15179-15188. 
  
37
(26) Edmondson, D. E., and Tollin, G. (1971) Circular dichroism studies of the flavin 
chromophore and of the relation between redox properties and flavin environment in 
oxidases and dehydrogenases. Biochemistry 10, 113-24. 
(27) Gadda, G. (2003) Kinetic mechanism of choline oxidase from Arthrobacter globiformis. 
Biochim. Biophys. Acta 1646, 112-8. 
(28) Cleland, W. W. (1982) The use of isotope effects to determine transition-state structure 
for enzymic reactions. Methods Enzymol. 87, 225. 
(29) Gadda, G. (2003) pH and deuterium kinetic isotope effects studies on the oxidation of 
choline to betaine-aldehyde catalyzed by choline oxidase. Biochim. Biophys. Acta. 1650, 
4-9. 
(30) Gadda, G., Powell, N. L., and Menon, P. (2004) The trimethylammonium headgroup of 
choline is a major determinant for substrate binding and specificity in choline oxidase. 
Arch. Biochem. Biophys. 430, 264-73. 
(31) Gadda, G., Fan, F., and Hoang, J. V. (2006) On the contribution of the positively charged 
headgroup of choline to substrate binding and catalysis in the reaction catalyzed by 
choline oxidase. Arch. Biochem. Biophys. 451, 182-7. 
(32) Fan, F., and Gadda, G. (2005) On the catalytic mechanism of choline oxidase. J. Am. 
Chem. Soc. 127, 2067-2074. 
(33) Fan, F., and Gadda, G. (2005) Oxygen- and temperature-dependent kinetic isotope effects 
in choline oxidase: correlating reversible hydride transfer with environmentally enhanced 
tunneling. J. Am. Chem. Soc. 127, 17954-61. 
(34) Knapp, M. J., and Klinman, J. P. (2002) Environmentally coupled hydrogen tunneling. 
Linking catalysis to dynamics. Eur. J. Biochem. 269, 3113-21. 
(35) Knapp, M. J., Rickert, K., and Klinman, J. P. (2002) Temperature-dependent isotope 
effects in soybean lipoxygenase-1: correlating hydrogen tunneling with protein dynamics. 
J. Am. Chem. Soc. 124, 3865-74. 
(36) Hatcher, E., Soudackov, A. V., and Hammes-Schiffer, S. (2004) Proton-coupled electron 
transfer in soybean lipoxygenase. J. Am. Chem. Soc. 126, 5763-75. 
  
38
(37) Fan, F., Germann, M. W., and Gadda, G. (2006) Mechanistic studies of choline oxidase 
with betaine aldehyde and its isosteric analogue 3,3-dimethylbutyraldehyde. Biochemistry 
45, 1979-86. 
(38) Ghanem, M., and Gadda, G. (2005) On the catalytic role of the conserved active site 
residue His466 of choline oxidase. Biochemistry 44, 893-904. 
(39) Ghanem, M., and Gadda, G. (2006) Effects of reversing the protein positive charge in the 
proximity of the flavin N(1) locus of choline oxidase. Biochemistry 45, 3437-47. 
(40) Yin, Y., Liu, P., Anderson, R. G., and Sampson, N. S. (2002) Construction of a 
catalytically inactive cholesterol oxidase mutant: investigation of the interplay between 
active site-residues glutamate 361 and histidine 447. Arch. Biochem. Biophys. 402, 235-
42. 
(41) Kass, I. J., and Sampson, N. S. (1998) Evaluation of the role of His447 in the reaction 
catalyzed by cholesterol oxidase. Biochemistry 37, 17990-8000. 
(42) Rotsaert, F. A., Renganathan, V., and Gold, M. H. (2003) Role of the flavin domain 
residues, His689 and Asn732, in the catalytic mechanism of cellobiose dehydrogenase 
from Phanerochaete chrysosporium. Biochemistry 42, 4049-56. 
(43) Wohlfahrt, G., Witt, S., Hendle, J., Schomburg, D., Kalisz, H. M., and Hecht, H. J. 
(1999) 1.8 and 1.9 Å resolution structures of the Penicillium amagasakiense and 
Aspergillus niger glucose oxidases as a basis for modelling substrate complexes. Acta. 
Crystallogr. D. Biol. Crystallogr. 55, 969-77. 
(44) Roth, J. P., and Klinman, J. P. (2003) Catalysis of electron transfer during activation of 
O2 by the flavoprotein glucose oxidase. Proc. Natl. Acad. Sci. U. S. A. 100, 62-7. 
(45) Hidaka, H., and Udenfriend, S. (1970) Evidence of a hydrazine-reactive group at the 
active site of the nonheme portion of horseradish peroxidase. Arch. Biochem. Biophys. 
140, 174-80. 
(46) Allison, W. S., Swain, L. C., Tracy, S. M., and Benitez, L. V. (1973) The inactivation of 
lactoperoxidase and the acyl phosphatase activity of oxidized glyceraldehyde-3-
phosphate dehydrogenase by phenlyhydrazine and phenyldiimide. Arch. Biochem. 
Biophys. 155, 400-4. 
  
39
(47) Saito, S., and Itano, H. A. (1981) β-meso-Phenylbiliverdin IX alpha and N-
phenylprotoporphyrin IX, products of the reaction of phenylhydrazine with 
oxyhemoproteins. Proc. Natl. Acad. Sci. U. S. A. 78, 5508-12. 
(48) Jonen, H. G., Werringloer, J., Prough, R. A., and Estabrook, R. W. (1982) The reaction of 
phenylhydrazine with microsomal cytochrome P-450. Catalysis of heme modification. J. 
Biol. Chem. 257, 4404-11. 
(49) Ortiz de Montellano, P. R., and Kerr, D. E. (1983) Inactivation of catalase by 
phenylhydrazine. Formation of a stable aryl-iron heme complex. J. Biol. Chem. 258, 
10558-63. 
(50) Patek, D. R., and Hellerman, L. (1974) Mitochondrial monoamine oxidase. Mechanism 
of inhibition by phenylhydrazine and by aralkylhydrazines. Role of enzymatic oxidation. 
J. Biol. Chem. 249, 2373-80. 
(51) Nagy, J., Kenney, W. C., and Singer, T. P. (1979) The reaction of phenylhydrazine with 
trimethylamine dehydrogenase and with free flavins. J. Biol. Chem. 254, 2684-8. 
(52) Fitzpatrick, P. F., and Villafranca, J. J. (1986) The mechanism of inactivation of 
dopamine β-hydroxylase by hydrazines. J. Biol. Chem. 261, 4510-8. 
(53) Lindström, A., Olsson, B., and Pettersson, G. (1974) Kinetics of the interaction between 
pig-plasma benzylamine oxidase and hydrazine derivatives. Eur. J. Biochem. 42, 177-82. 
(54) Schiele, B. C. (1963) Antidepressants: comparison of clinical effects in anergic 
schizophrenia and the depressed states. Ann. N. Y. Acad. Sci. 107, 1131-8. 
(55) Kim, J. M., Hoegy, S., E., and Mariano, P. S. (1995) Flavin chemical models for 
monoamine oxidase inactivation by cyclopropylamines, α-silylamines, amd hydrazines. 
J. Am. Chem. Soc. 117, 100-5. 
(56) Mitchell, D. J., Nikolic, D., Jang, M. H., van Breemen, R. B., Hille, R., and Silverman, R. 
B. (2001) Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-
methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine. Biochemistry 40, 
8523-30. 
  
40
(57) Barsky, J., Pacha, W. L., Sarkar, S., and Zeller, E. A. (1959) Amine oxidases. XVII. 
Mode of action of 1-isonicotinyl-2-isopropylhydrazine on monoamine oxidase. J. Biol. 
Chem. 234, 389-91. 
(58) Zeller, E. A. (1963) A new approach to the analysis of the interaction between 
monoamine oxidase and its substrates and inhibitors. Ann. N. Y. Acad. Sci. 107, 811-21. 
(59) Bloom, B. M. (1963) Some structural considerations regarding compounds that influence 
monoamine metabolism. Ann. N. Y. Acad. Sci. 107, 878-90. 
(60) Hellerman, L., and Erwin, V. G. (1968) Mitochondrial monoamine oxidase. II. Action of 
various inhibitors for the bovine kidney enzyme. Catalytic mechanism. J. Biol. Chem. 
243, 5234-43. 
(61) Smith, T. E., Weissbach, H., and Udenfriend, S. (1963) Studies on monoamine oxidase: 
The mechanism of inhibition of monoamine oxidase by iproniazid. Biochemistry 2, 746-
51. 
(62) Eberson, L. E., and Persson, K. (1962) Studies on monoamine oxidase inhibitors. I. The 
autoxidation of β-phenylisopropylhydrazine as a model reaction for irreversible 
monoamine oxidase inhibition. J. Med. Pharm. Chem. 91, 738-52. 
(63) Green, A. L. (1964) Studies on the mechanism of inhibition of monoamine oxidase by 
hydrazine derivatives. Biochem. Pharmacol. 13, 249-61. 
(64) Davison, A. N. (1957) The mechanism of the irreversible inhibition of rat-liver 
monoamine oxidase by iproniazid (marsilid). Biochem. J. 67, 316-22. 
(65) Steenkamp, D. J., and Gallup, M. (1978) The natural flavorprotein electron acceptor of 
trimethylamine dehydrogenase. J. Biol. Chem. 253, 4086-9. 
(66) Colby, J., and Zatman, L. J. (1974) Purification and properties of the trimethylamine 
dehydrogenase of bacterium 4B6. Biochem. J. 143, 555-67. 
(67) Ghisla, S., and Mayhew, S. G. (1973) Identification and structure of a novel flavin 
prosthetic group associated with reduced nicotinamide adenine dinucleotide 
dehydrogenase from Peptostreptococcus elsdenii. J. Biol. Chem. 248, 6568-70. 
  
41
(68) Mazumdar, A., Adak, S., Chatterjee, R., and Banerjee, R. K. (1997) Mechanism-based 
inactivation of lacrimal-gland peroxidase by phenylhydrazine: a suicidal substrate to 
probe the active site. Biochem. J. 324 ( Pt 3), 713-9. 
(69) Morrison, M., and Allen, P. Z. (1966) Lactoperoxidase: identification and isolation from 
Harderian and lacrimal glands. Science 152, 1626-8. 
(70) Ringe, D., Petsko, G. A., Kerr, D. E., and Ortiz de Montellano, P. R. (1984) Reaction of 
myoglobin with phenylhydrazine: a molecular doorstop. Biochemistry 23, 2-4. 
(71) Ortiz de Montellano, P. R., and Kerr, D. E. (1985) Inactivation of myoglobin by ortho-
substituted arylhydrazines. Formation of prosthetic heme aryl-iron but not N-aryl adducts. 
Biochemistry 24, 1147-52. 
(72) Ortiz de Montellano, P. R., Kunze, K. L., Cole, S. P., and Marks, G. S. (1981) 
Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin 
IX. Biochem. Biophys. Res. Commun. 103, 581-6. 
(73) Augusto, O., Beilan, H. S., and Ortiz de Montellano, P. R. (1982) The catalytic 
mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate 
oxidation. J. Biol. Chem. 257, 11288-95. 
(74) Wormall, A. (1930) The immunological specificity of chemically altered proteins: 
Halogenated and nitrated proteins. J. Exp. Med. 51, 295-317. 
(75) Sokolovsky, M., Riordan, J. F., and Vallee, B. L. (1966) Tetranitromethane. A reagent for 
the nitration of tyrosyl residues in proteins. Biochemistry 5, 3582-9. 
(76) Maley, J. R., and Bruice, T. C. (1968) Catalytic reactions involving azomethines. X. 
Transamination of 1-methyl-4-formylpyridinium iodide. J. Am. Chem. Soc. 90, 2843-7. 
(77) Sokolovsky, M., Harell, D., and Riordan, J. F. (1969) Reaction of tetranitromethane with 
sulfhydryl groups in proteins. Biochemistry 8, 4740-5. 
(78) Glover, D. J., and Landsman, S. G. (1964) Spectrophotometric method for determination 
of tetranitromethane in solution and in air Anal. Chem. 36, 1690-1. 
  
42
(79) Gadda, G., Banerjee, A., and Fitzpatrick, P. F. (2000) Identification of an essential 
tyrosine residue in nitroalkane oxidase by modification with tetranitromethane. 
Biochemistry 39, 1162-8. 
(80) Nagpal, A., Valley, M. P., Fitzpatrick, P. F., and Orville, A. M. (2006) Crystal structures 
of nitroalkane oxidase: Insights into the reaction mechanism from a covalent complex of 
the flavoenzyme trapped during turnover. Biochemistry 45, 1138-1150. 
(81) Mattevi, A., Vanoni, M. A., Todone, F., Rizzi, M., Teplyakov, A., Coda, A., Bolognesi, 
M., and Curti, B. (1996) Crystal structure of D-amino acid oxidase: a case of active site 
mirror-image convergent evolution with flavocytochrome b2. Proc. Natl. Acad. Sci. U. S. 
A. 93, 7496-501. 
(82) Xia, Z. X., and Mathews, F. S. (1990) Molecular structure of flavocytochrome b2 at 2.4 Å 
resolution. J. Mol. Biol. 212, 837-63. 
(83) Schreuder, H. A., Prick, P. A., Wierenga, R. K., Vriend, G., Wilson, K. S., Hol, W. G., 
and Drenth, J. (1989) Crystal structure of the p-hydroxybenzoate hydroxylase-substrate 
complex refined at 1.9 Å resolution. Analysis of the enzyme-substrate and enzyme-
product complexes. J. Mol. Biol. 208, 679-96. 
(84) Lindqvist, Y., and Branden, C. I. (1989) The active site of spinach glycolate oxidase. J. 
Biol. Chem. 264, 3624-8. 
(85) Gomez, G., Pikal, M. J., and Rodriguez-Hornedo, N. (2001) Effect of initial buffer 
composition on pH changes during far-from-equilibrium freezing of sodium phosphate 
buffer solutions. Pharm. Res. 18, 90-7. 
(86) Pikal-Cleland, K. A., Rodriguez-Hornedo, N., Amidon, G. L., and Carpenter, J. F. (2000) 
Protein denaturation during freezing and thawing in phosphate buffer systems: 
monomeric and tetrameric β-galactosidase. Arch. Biochem. Biophys. 384, 398-406. 
(87) Jiang, S., and Nail, S. L. (1998) Effect of process conditions on recovery of protein 
activity after freezing and freeze-drying. Eur. J. Pharm. and Biopharm. 45, 249-257. 
(88) Orii, Y., and Morita, M. (1977) Measurement of the pH of frozen buffer solutions by 
using pH indicators. J. Biochem. (Tokyo) 81, 163-8. 
  
43
(89) Ken-ichi, I., Sumie, Y., and Tadao, T. (1993) Stabilization of β-galactosidase by 
amphiphilic additives during freeze-drying  Int. J. of Pharm. 90, 187-194. 
(90) Degraeve, P., Delorme, P., and Lemay, P. (1996) Pressure-induced inactivation of E. coli 
β-galactosidase: influence of pH and temperature. Biochim. Biophys. Acta. 1292, 61-8. 
(91) Tenu, J. P., Viratelle, O. M., Garnier, J., and Yon, J. (1971) pH dependence of the 
activity of β-galactosidase from Escherichia coli. Eur. J. Biochem. 20, 363-70. 
(92) Tenu, J. P., Viratelle, O. M., and Yon, J. (1972) Kinetic study of the activation process of 
β-galactosidase from Escherichia coli by Mg2+. Eur. J. Biochem. 26, 112-8. 
(93) van den Berg, L., and Rose, D. (1959) Effect of freezing on the pH and composition of 
sodium and potassium phosphate solutions; the reciprocal system KH2PO4-Na2-HPO4-
H2O. Arch. Biochem. Biophys. 81, 319-29. 
(94) Murase, N., and Franks, F. (1989) Salt precipitation during the freeze-concentration of 
phosphate buffer solutions. Biophys. Chem. 34, 293-300. 
(95) Curti, B., Massey, V., and Zmudka, M. (1968) Inactivation of snake venom L-amino acid 
oxidase by freezing. J. Biol. Chem. 243, 2306-14. 
(96) Frieden, C. (1970) Kinetic aspects of regulation of metabolic processes. The hysteretic 
enzyme concept. J. Biol. Chem. 245, 5788-99. 
(97) Deits, T., and Shapiro, B. M. (1985) pH-induced hysteretic transitions of ovoperoxidase. 
J. Biol. Chem. 260, 7882-8. 
(98) Baici, A., Szedlacsek, S. E., Fruh, H., and Michel, B. A. (1996) pH-dependent hysteretic 
behaviour of human myeloblastin (leucocyte proteinase 3). Biochem. J. 317 ( Pt 3), 901-
5. 
(99) Frieden, C. (1979) Slow transitions and hysteretic behavior in enzymes. Annu. Rev. 
Biochem. 48, 471-89. 
(100) Bae, J. H., Anderson, S. H., and Miller, K. J. (1993) Identification of a high-affinity 
glycine betaine transport system in Staphylococcus aureus. Appl. Environ. Microbiol. 59, 
2734-6. 
  
44
(101) Culham, D. E., Emmerson, K. S., Lasby, B., Mamelak, D., Steer, B. A., Gyles, C. L., 
Villarejo, M., and Wood, J. M. (1994) Genes encoding osmoregulatory proline/glycine 
betaine transporters and the proline catabolic system are present and expressed in diverse 
clinical Escherichia coli isolates. Can. J. Microbiol. 40, 397-402. 
(102) Graham, J. E., and Wilkinson, B. J. (1992) Staphylococcus aureus osmoregulation: roles 
for choline, glycine betaine, proline, and taurine. J. Bacteriol. 174, 2711-6. 
(103) Kaenjak, A., Graham, J. E., and Wilkinson, B. J. (1993) Choline transport activity in 
Staphylococcus aureus induced by osmotic stress and low phosphate concentrations. J. 
Bacteriol. 175, 2400-6. 
(104) Kunin, C. M., and Rudy, J. (1991) Effect of NaCl-induced osmotic stress on intracellular 
concentrations of glycine betaine and potassium in Escherichia coli, Enterococcus 
faecalis, and staphylococci. J. Lab. Clin. Med. 118, 217-24. 
(105) Le Rudulier, D., Bernard, T., Goas, G., and Hamelin, J. (1984) Osmoregulation in 
Klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen fixation under 
stress by proline betaine, gamma- butyrobetaine, and other related compounds. Can. J. 
Microbiol. 30, 299-305. 
(106) Le Rudulier, D., and Bouillard, L. (1983) Glycine betaine, an osmotic effector in 
Klebsiella pneumoniae and other members of the Enterobacteriaceae. Appl. Environ. 
Microbiol. 46, 152-9. 
(107) Pichereau, V., Bourot, S., Flahaut, S., Blanco, C., Auffray, Y., and Bernard, T. (1999) 
The osmoprotectant glycine betaine inhibits salt-induced cross- tolerance towards lethal 
treatment in Enterococcus faecalis. Microbiology 145, 427-35. 
(108) Pourkomailian, B., and Booth, I. R. (1992) Glycine betaine transport by Staphylococcus 
aureus: evidence for two transport systems and for their possible roles in osmoregulation. 
J. Gen. Microbiol. 138, 2515-8. 
(109) Peddie, B. A., Wong-She, J., Randall, K., Lever, M., and Chambers, S. T. (1998) 
Osmoprotective properties and accumulation of betaine analogues by Staphylococcus 
aureus. FEMS Microbiol. Lett. 160, 25-30. 
(110) Alia, Kondo, Y., Sakamoto, A., Nonaka, H., Hayashi, H., Saradhi, P. P., Chen, T. H., and 
Murata, N. (1999) Enhanced tolerance to light stress of transgenic Arabidopsis plants that 
express the codA gene for a bacterial choline oxidase. Plant Mol. Biol. 40, 279-88. 
  
45
(111) Deshnium, P., Gombos, Z., Nishiyama, Y., and Murata, N. (1997) The action in vivo of 
glycine betaine in enhancement of tolerance of Synechococcus sp. strain PCC 7942 to 
low temperature. J. Bacteriol. 179, 339-44. 
 
 
  
46
Chapter II 
MATERIAL AND METHODS 
 
1. Materials and Enzyme Preparations 
Choline chloride was from ICN Pharmaceutical (Aurora, OH). Glycine betaine was from 
Sigma-Aldrich (St. Louis, MO). 2-Hydazino-N,N,N-trimethyl-2-oxo-ethanaminium chloride was 
purchased from Acros Organics N.V. (Fair Lawn, NJ).  Trans-2-phenylcyclopropylamine, 
isonicotinic acid, 3-dimetylamino-1-propyne, allyltrimethylammonium chloride, 
phenylhydrazine, and tetranitromethane were from Aldrich. TPCK-treated trypsin was purchased 
from Worthington.  Recombinant choline oxidase from Arthrobacter globiformis strain ATCC 
8010 was expressed from plasmid pET/codA1 and purified to homogeneity as described 
previously (1). Fully oxidized choline oxidase was prepared as described in ref. (2), and was 
stored at -20 oC in either 20 mM Tris-Cl, pH 8, or 20 mM sodium phosphate, 20 mM sodium 
pyrophosphate, pH 6. The enzyme was rapidly thawed on ice prior of each experiment. When 
needed, buffers were changed either by gel filtration through disposable PD-10 desalting 
columns (Amersham Pharmacia Biotech, Piscataway, NJ) or dialysis for 19 h at 4 oC. The 
concentration of choline oxidase was determined spectrophotometrically at 454 nm using the 
previously reported ε454 value of 11.4 mM-1cm-1 (3).  All kinetic parameters determined were 
expressed per active site oxidized flavin content (3). All other reagents were of the highest purity 
commercially available. 
 
2. Instruments 
 UV-visible absorbance spectra were recorded using an Agilent Technologies diode-array 
spectrophotometer model HP 8453 equipped with a thermostated water bath.  Tryptic maps were 
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obtained using a high performance liquid chromatograph (HPLC) model LC-10AT from 
Shimadzu.  Fluorescence emission spectra were recorded with a Shimadzu Spectrofluorometer 
model RF-5301 PC thermostated at 15 oC. Circular dichroism spectra were acquired using a 
Jasco J-810 spectropolarimeter at 5 oC. Enzyme activity was measured polarographically by 
monitoring the rate of oxygen consumption with a Hansatech oxygen electrode (HansaTech Oxy-
32) thermostated at 25 oC.  
 
3. Enzyme Assay 
 Enzyme activity was measured with the method of the initial rates (4) in air-saturated 50 
mM potassium phosphate at pH 7 by monitoring the rate of oxygen consumption with a 
computer-interfaced Oxy-32 oxygen-monitoring system  (Hansatech Instrument Ltd.) 
thermostated at 25 oC. The reactions were started by the addition of choline oxidase to a 1 ml 
reaction mixture.  Unless otherwise stated, the final concentration of enzyme in the reaction 
mixture was in 0.1 to 0.5 µM range, and the concentration of choline was between 0.05 and 10 
mM.   
 Chemical modification was carried out by incubating the enzyme in 20 mM Tris-Cl at pH 
8 and 20 oC in the presence of ligand.  The concentration of ligand in the incubation was in a 
range from 0.5 and 50 mM.  At different times, aliquots were withdrawn and assayed 
polarographically for enzymatic activity with choline as substrate. 
 For freezing inactivation study, rates of oxygen consumptions of the enzyme species 
showing slow onsets of steady state during turnover were determined from the linear portions of 
the traces, i.e., after steady state was achieved.  The pH effects on the fast rate of reactivation of 
choline oxidase (kc) were determined by measuring the activity of the enzyme species with 
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hysteretic behavior in 50 mM [Tris (hydroxymethyl) aminomethane] with the pH in a range from 
6.5 to 9.6 at 25 oC.  The temperature effects on the slow rate of activation of choline oxidase 
(kact) were determined by incubating the inactive enzyme in the range from 20 to 39 oC at pH 6, 
and the activity was measured in 50 mM morpholinoethansulfonic acid, at pH 6 and 25 oC. 
 
4. Tryptic Digestion 
 To identify the modified site by mechanism-based inhibitor that resulted in enzyme 
inactivation, the enzyme was incubated with the inhibitors in the presence and absence of 140 
mM glycine betaine in 20 mM Tris-Cl at pH 8 and 20 oC.  Enzyme activity was monitored over 
time until ~90% of the enzyme became inactivated.  Gel filtration was used to remove the excess 
reagents.  The inactive enzyme was denatured with 10% (w/v) trichloroacetic acid and incubated 
on ice for 30 min before centrifugation at 12000g for 20 min. The pellets were washed with 10% 
trichloroacetic acid followed by an ice-cold acetone/HCl (39:1) mixture, resuspended in 0.1 mL 
of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium bicarbonate, pH 8, and allowed to stand for 1 h 
at 37 C. The solutions were then diluted with 0.3 mL of water before the addition of trypsin to 
a final concentration of 3% (w/w, trypsin/choline oxidase). After 4 h incubation at 37 C, a 
second aliquot of trypsin (1% w/w final concentration) was added, and the mixture was allowed 
to react for a further 15 h at 37 C. The digestion was stopped with trifluoroacetic acid (1% final 
concentration). Purification of peptides was carried out by HPLC using a Shimadzu instrument 
equipped with a model SPD-M10A photodiode array detector and a µBondapak C18 (15 × 4.6 
mm) reverse-phase column at a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous 
trifluoroacetic acid, and eluent B was 0.04% trifluoroacetic acid in acetonitrile. The 
chromatography was carried out with a linear gradient from 5% to 50% eluent B over 90 min. 
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Peptides were collected manually.  For the identification of the modified peptide, MALDI-TOF 
mass spectrometry was used in both the positive and negative ion modes with 50:50 
methanol/acetonitrile matrix. 
 
5. Spectral Studies 
 In freezing inactivation study, absorbance, fluorescence, and circular dichroic spectra 
were determined in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6, at 15 oC. 
The concentration of enzyme in flavin content was: 11 µM for the UV-visible absorbance 
spectra, 3 µM for the protein fluorescence emission spectra (with λex at 285 nm), 11 µM for the 
flavin fluorescence emission (with λex at ~455 nm), and 2.5 µM, 50 µM, and 168 µM for the CD 
spectra of the protein in the far-UV, near-UV, and visible regions of the spectra, respectively. 
 
6. Data Analysis 
 Data were fit with KaleidaGraph software (Synergy Software, Reading, PA) and Enzfitter 
software (Biosoft, Cambridge, UK).  The steady state kinetic parameters were determined by 
fitting the data to the Michaelis-Menten equation for one substrate.  Time course of inactivation 
of choline oxidase was fit with eq (1), where A represents the residual activity at a given time (t), 
A0 is the initial activity, and kobs is the observed rate of the inactivation.  The rates of inactivation 
of the enzyme were fit to eq (2), where kinact is the first-order rate constant for the conversion of 
the reversibly formed enzyme-inhibitor complex to irreversibly inactivated enzyme, I is the 
concentration of the mechanism-based inhibitor, and KI is the dissociation constant of the 
mechanism-based inhibitor from the enzyme. 
tkeAA obs0
−=    (1) 
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 In freezing inactivation study, the first-order rate constants for the fast and pH-dependent 
activation of the inactive form of choline oxidase (kc) were determined by fitting the time-
courses of oxygen consumption to eq 3, which was modified from Frieden (5), where vf 
represents the observed rate of reaction after reaching steady state, and [O2]o is the initial 
concentration of oxygen. The pH dependence of kc was determined by using eq 4, which 
describes a curve with a slope of +1 and a plateau region at high pH where C represents the pH-
independent value. The apparent rates of activation of the enzyme at any given temperature were 
determined by fitting the observed rates of oxygen consumption at any given incubation time 
with eq 5 that describes a single exponential process. Here, appkact is the apparent first-order rate 
constant for the temperature-dependent slow activation of the inactive form of choline oxidase, t 
is time, At is the value of enzymatic activity, Ao is the amplitude of the total change, and A∞ is the 
enzymatic activity at infinite time. The temperature dependence of kact was determined by using 
the Eyring's equation (eq 6), where kact is the first-order rate constant for enzyme activation, kB 
and h are the Boltzmann and Planck constants, T is the absolute temperature in Kelvin, R is the 
gas constant with a value of 8.315 J mol-1 K-1, and ∆H‡ and ∆S‡ are the enthalpy and entropy of 
activation, respectively. 
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Chapter III 
CHEMICAL MODIFICATION OF CHOLINE OXIDASE: THE SEARCH FOR THE 
INHIBITOR 
 
Abstract 
 Choline oxidase is a flavin-dependent enzyme that catalyzes the oxidation of choline to 
glycine-betaine, with oxygen as electron acceptor.  In the absence of crystallographic data, 
chemical modification was employed in order to identify essential catalytic residues in the active 
site of choline oxidase.  Because mechanism-based inhibitors are needed for the modification of 
enzyme, seven reagents were tested in this study as inhibitors for choline oxidase: 2-hydrazino-
N,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid hydrazide, 3-
dimethylamino-1-propyne, trans-2-phenylcyclopropylamine, phenylhydrazine, and 
tetranitromethane.  The results showed significant inactivation of the enzyme with 
tetranitromethane and phenylhydrazine at concentration ranging from 0.5 to 5.0 mM and 0.1 to 
2.0 mM, respectively.  The observed inactivation rates at these concentrations ranged from 0.1 to 
0.4 h-1 with tetranitromethane and from 0.5 to 4.4 h-1 with phenylhydrazine.  Enzyme 
inactivation was also observed with trans-2-phenylcyclopropylamine in the concentration range 
from 10 to 50 mM to yield a kobs value from 0.2 to 0.3 h-1, respectively.  The results in this study 
helped identifying three possible inhibitors that might be used for the modification of choline 
oxidase. 
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Introduction 
 Choline oxidase (CHO; E.C. 1.1.3.17) from Arthrobacter globiformis catalyzes the 
oxidation of choline to glycine betaine through two flavin-linked sequential hydride transfers 
with betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor 
(Scheme 3.1). 
(CH3)3N
+ OH
H2O2
(CH3)3N
+ O
H2O2
O2
(CH3)3N
+ O
O
H2O, O2Choline Betaine aldehyde Betaine  
Scheme 3.1.  Reaction catalyzed by choline oxidase. 
 
The enzyme is a homodimer of 120 kDa, with each monomer containing covalently bound FAD 
(1).  The study of choline oxidase was considered of importance to both medical and 
biotechnological applications because the product of its catalytic reaction, glycine betaine, was 
found to accumulate in the cytoplasm of cells to prevent dehydration and plasmolysis in adverse 
hyperosmotic environments (2, 3) in pathogenic bacteria (4-13) and transgenic plants (14-19).  
Consequently, the study of choline oxidase has potential for the development of therapeutic 
agents targeted at the inhibition of glycine betaine biosynthesis and for the engineering of 
drought resistance in economically relevant crops. 
 In earlier work, we have reported the cloning and expression of the gene coding for 
choline oxidase from A. globiformis strain ATCC 8010 in E. coli (1).  The chemical mechanism 
for the oxidation of choline catalyzed by choline oxidase has been recently elucidated using 
kinetic isotope effects, and is consistent with the quantum mechanical transfer of a hydride from 
the substrate α-carbon to the enzyme-bound flavin cofactor occurring from an activated alkoxide 
form of choline (20, 21). Such an alkoxide species has been proposed to form by the action of an 
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active site base with pKa of ~7.5 (22-24), and to be electrostatically stabilized in the enzyme 
active site by the imidazolium side chain of His466 (25, 26).   
 Despite the wealth of information that has previously been obtained on choline oxidase 
using kinetic and mechanistic studies, the lack of 3-dimensional structure hindered the 
understanding of the catalytic reaction at structural level.  In the absence of crystallographic data, 
chemical modification is a powerful technique that can be used to identify the essential residues 
in the active site of enzyme.  This technique involves experiment with mechanism-based 
inhibitors of the enzyme.  If the inhibitor reacts with side chains of an amino acid and lead to 
enzyme inactivation, then it is very likely that this amino acid plays important roles in enzyme 
function, such as participating directly in catalytic process, participating in binding interaction 
with a substrate, or stabilizing the enzyme conformation that is required for catalysis.  In this 
chapter, several reagents were employed for the chemical modification studies of choline 
oxidase, in which only the highly reactive and selective reagents will be chosen for more detailed 
study. 
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Material and Methods 
 Materials and enzyme preparations.  Choline chloride was from ICN Pharmaceutical 
(Aurora, OH). Glycine betaine was from Sigma-Aldrich (St. Louis, MO). 2-hydazino-N,N,N-
trimethyl-2-oxo-ethanaminium chloride was purchased from Acros Organics N.V. (Fair Lawn, 
NJ).  Trans-2-phenylcyclopropylamine, isonicotinic acid, 3-dimetylamino-1-propyne, 
allyltrimethylammonium chloride, phenylhydrazine, and tetranitromethane were from Aldrich. 
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ).  Recombinant choline 
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid 
pET/codA1 and purified to homogeneity as described previously (1). Fully oxidized choline 
oxidase was prepared as described in ref. (24), and was stored at -20 oC in either 20 mM Tris-Cl, 
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was 
rapidly thawed on ice prior of each experiment.  The concentration of choline oxidase was 
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4 
mM-1cm-1 (23).  All kinetic parameters determined were expressed per active site oxidized flavin 
content (23). All other reagents were of the highest purity commercially available. 
 Instruments.  Inactivation of enzyme was carried out by incubating the enzyme with the 
inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was 
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech 
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC.  
 Enzyme assays.  The enzyme was incubated in 20 mM Tris-Cl at pH 8 and 20 oC in the 
presence of chosen reagent.  At different times, aliquots were withdrawn and assayed 
polarographically for enzymatic activity.  Enzyme activity was measured with the method of the 
initial rates (27) in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of 
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oxygen consumption with a computer-interfaced Oxy-32 oxygen-monitoring system  (Hansatech 
Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline 
oxidase to a 1 ml reaction mixture.  Unless otherwise stated, the final concentration of enzyme in 
the reaction mixture was in the 0.1 to 0.5 µM range, and the concentration of choline was 10 
mM.    
 Data analysis.  Data were fit with KaleidaGraph software (Synergy Software, Reading, 
PA).  The steady state kinetic parameters were determined by fitting the data to the Michaelis-
Menten equation for one substrate.  Time course of inactivation of choline oxidase was fit with 
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and 
kobs is the observed rate of the inactivation.   
 tkeAA obs0
−=    (1) 
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Results 
 In order to ensure that enzyme inactivation was only due to the reaction of choline 
oxidase with the reagent being tested, a control experiment was carried out in which the enzyme 
was incubated in 20 mM Tris-Cl, pH 8, at 20 oC.  As show in Figure 3.1, the residual activity of 
choline oxidase remained constant up to two hours of incubation; therefore, all inactivation 
experiments were done under these conditions. 
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Figure 3.1.  Stability of choline oxidase in 20 mM Tris-Cl, pH 8, at 20 oC.  Enzyme activity was 
measured by monitoring the rate of oxygen consumption in air-saturated 50 mM potassium 
phosphate at pH 7 and 25 oC.  The data were fit with Eq. (1). 
 
 Seven reagents were chosen to test as inhibitors of choline oxidase in 20 mM Tris-Cl, pH 
8, at 20 oC (Table 3.1).  The choice of reagents was based on structural similarity of the reagents 
with the substrates or product of the enzyme or the previously studied inhibitory mechanism of 
the reagents.  As shown in Table 3.1, there was no enzyme inactivation observed with 2-
hydrazino-N,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid 
hydrazide, and 3-dimethylamino-1-propyne.  In contrast, significant enzyme inactivation was 
observed with phenylhydrazine and tetranitromethane.  Trans-2-phenylcyclopropylamine also 
inactivated choline oxidase but at an observed rate that was ~200-fold less than that of 
phenylhydrazine and 40-fold slower than that of tetranitromethane. 
kobs = ~0 min-1 
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Table 3.1.  List of reagents tested as mechanism-based inhibitors for choline oxidase.a 
Reagent name Structure Concentrations, 
mM 
kobs,b 
h-1 
2-hydrazino-N,N,N-trimethyl- 
2-oxo-ethanaminium N
CH3
H3C
CH3
H
N
NH2
O  
20-50 0 
allyltrimethylammonium 
N
CH3
H3C
CH3  
20-50 0 
isonicotinic acid hydrazide 
N
N
H
NH2
O
 
20-50 0 
trans-2- 
phenylcyclopropylamine NH2
 
10-50 0.2-0.3 
phenylhydrazine H
N
NH2
 
0.1-2.0 0.5-4.4 
3-dimethylamino-1-propyne 
N
CH3
H3C  
10-50 0 
tetranitromethane NO2
NO2
NO2
O2N
 
0.5-5.0 0.1-0.4 
a Data were obtained by incubating the enzyme with the reagent in 20 mM Tris-Cl, pH 
8, at 20 oC. Activity was monitored over time with choline as substrate in 50 mM 
potassium phosphate, pH 7, at 25 oC. 
b Observed rate of enzyme inactivation, which was determined by fitting the residual 
activity at a given time t to the single exponential decay equation (Eq. 1). 
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Discussion 
 The flavoprotein choline oxidase from Arthrobacter globiformis catalyzes the two steps 
oxidation of a primary alcohol substrate to a carboxylate product with an aldehyde intermediate.  
In the absence of crystallographic data, chemical modification was employed in order to identify 
essential catalytic residues in the active site of choline oxidase.  The study presented herein 
helped identifying mechanism-based inhibitors that may be used for enzyme modification.  Out 
of the seven reagents tested (Table 3.1), the enzyme showed significant inactivation rates only 
with tetranitromethane, phenylhydrazine, and trans-2-phenylcyclopropylamine.  
Tetranitromethane (TNM) has been used for chemical modification of amino acid residues in 
peptides, polymers, and proteins since 1930 (28-30).  This reagent is well known for its high 
specificity for the nitration of tyrosyl residues with distinct visible absorbance that can be 
quantitated using spectrophotometry (30).  Phenylhydrazine and trans-2-
phenylcyclopropylamine has been used in modification of flavoenzymes such as monoamine 
oxidase (31, 32) and trimethylamine dehydrogenase (33, 34).  Enzyme inactivation with these 
two reagents usually involves the generation of a carbon-centered radical or anion at the enzyme 
active site, resulting in the formation of flavin C4(a) adduct.  In this study, significant 
inactivation rates were observed for choline oxidase with all three reagents; however, more 
specific experiments must be performed in order to distinguish the amino acid that has been 
modified.  Detailed studies on the modification of choline oxidase with phenylhydrazine and 
tetranitromethane are illustrated in Chapter 4 and Chapter 5, respectively. 
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Chapter IV 
CHEMICAL MODIFICATION OF CHOLINE OXIDASE WITH PHENYLHYDRAZINE 
 
Abstract 
 The four electron-oxidation of choline to glycine betaine was catalyzed choline oxidase 
through two flavin-dependent hydride-transfer steps within the same active site.  When choline 
oxidase was incubated with phenylhydrazine in 20 mM Tris-Cl at pH 8 and 20 oC, there was an 
irreversible loss of enzymatic activity.  The inactivation of choline oxidase by phenylhydrazine 
was both time and concentration dependent with a second-order rate constant of 0.04 mM-1 min-
1.  The enzyme was fully protected from inactivation when there was a ligand in the enzyme 
active site, indicating the inactivation by phenylhydrazine is active-site directed.  
Phenylhydrazine could be use as a substrate of choline oxidase, but substrate-inhibition 
mechanism was observed at concentration ≥20 mM.   The inactivation of the enzyme by 
phenylhydrazine associated with the bleaching of the 454 nm peak and an increase in absorbance 
at 370 nm, suggesting the formation of flavin semiquinone.  However, the percentage of 
remaining residual activity was 3 times lower than the remaining oxidized enzyme; therefore, the 
generation of flavin semiquinone is not fully responsible for enzyme inactivation.  The tryptic 
maps of protected and unprotected enzyme samples were compared, but no specific modification 
site was identified due to nonselective reactivity of phenylhydrazine. 
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Introduction 
 Choline oxidase (CHO; E.C. 1.1.3.17) from Arthrobacter globiformis was first purified 
by Ikuta et. al. in 1977 (1).  The enzyme is a homodimer with a mass of 120 kDa that catalyzes 
the oxidation of choline to glycine betaine through two flavin-linked sequential hydride transfers 
with betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor 
(Scheme 4.1). 
(CH3)3N
+ OH
H2O2
(CH3)3N
+ O
H2O2
O2
(CH3)3N
+ O
O
H2O, O2Choline Betaine aldehyde Betaine  
Scheme 4.1.  Reaction catalyzed by choline oxidase. 
 
The study of choline oxidase is of interest to the understanding of glycine betaine biosynthesis in 
pathogenic bacteria (2-11) and transgenic plants (12-17) as a response dehydration and salt stress 
in adverse hyperosmotic environments (18, 19). The detail biosynthesis mechanism of glycine 
betaine can be used in the research for therapeutic agents that target the inhibition of glycine 
betaine biosynthesis and for the engineering of drought resistance in economically relevant 
crops. 
 In the past decade, the biotechnological and medical applications of choline oxidase have 
been studied extensively, but there was no reported study on the catalytic mechanism of the 
enzyme.  Until just recently, we have reported the cloning and expression of the gene coding for 
choline oxidase from A. globiformis strain ATCC 8010 in E. coli (20).  With the excess 
availability of the enzyme, a number of kinetics and mechanistic studies have been carried out in 
our laboratory.  The chemical mechanism for the oxidation of choline was understood based on 
data from kinetic isotope effects, which suggested the quantum mechanical transfer of a hydride 
from the substrate α-carbon to the enzyme-bound flavin cofactor occurring from an activated 
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alkoxide form of choline (21, 22). The pH and kinetic isotope effects on the kinetic parameters 
kcat and kcat/Km with choline as substrate gave evidence to the participation of active site base 
with pKa of ~7.5 in catalysis (23, 24).  The roles of His466 in the active site of choline oxidase 
were also established by substituting it with an alanine or an asparatate (25, 26).  Based on 
spectroscopic and kinetic properties of H466A and H466D mutants, His466 is believed to be 
responsible for the stabilization of the negative charges on the alkoxide species of choline and on 
the N(1)-C(2)=O region of the flavin and contributed into the polarity of the active site of choline 
oxidase.  
 Even though we have gained insights into the catalytic mechanism of choline oxidase 
with kinetic and mechanistic techniques, the understanding of detailed catalytic strategy of this 
enzyme is still limited at structural level.  In the absence of X-ray crystallographic data, chemical 
modification with irreversible inhibitors can be used to identify essential residue in the active site 
of the enzyme.  In this study, phenylhydrazine was used to inactivate the enzyme.  The kinetic 
and mechanistic data from the inactivation were determined using spectrophotometric and 
chromatographic techniques.  Identification of the modification site that responsible for the 
inactivation of the enzyme were performed using tryptic digestion, HPLC, and mass 
spectrometry. 
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Experimental Procedures 
 Materials and enzyme preparations.  Choline chloride was from ICN Pharmaceutical 
(Aurora, OH). Glycine betaine and phenylhydrazine were from Sigma-Aldrich (St. Louis, MO). 
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ).  Recombinant choline 
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid 
pET/codA1 and purified to homogeneity as described previously (20). Fully oxidized choline 
oxidase was prepared as described in ref. (27), and was stored at -20 oC in either 20 mM Tris-Cl, 
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was 
rapidly thawed on ice prior of each experiment.  The concentration of choline oxidase was 
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4 
mM-1cm-1 (24).  All kinetic parameters determined were expressed per active site oxidized flavin 
content (24). All other reagents were of the highest purity commercially available. 
 Instruments.  Inactivation of enzyme was carried out by incubating the enzyme with the 
inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was 
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech 
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC.  UV-visible absorbance spectra 
were recorded on a Hewlett-Packard 8453A diode array spectrophotometer.  Purification of 
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPD-
M10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column. 
 Enzyme assays.  Enzyme activity was measured with the method of the initial rates (28) 
in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen 
consumption with a computer-interfaced Oxy-32 oxygen-monitoring system  (Hansatech 
Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline 
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oxidase to a 1 ml reaction mixture.  Unless otherwise stated, the final concentration of enzyme in 
the reaction mixture was in 0.1 to 0.5 µM range, and the concentration of choline was 10 mM.   
The enzyme was inactivated by incubating in 20 mM Tris-Cl at pH 8 and 20 oC in the presence 
of phenylhydrazine.  At different times, aliquots were withdrawn and assayed polarographically 
for enzymatic activity.  Stock solution of phenylhydrazine was prepared just prior to use. 
 Tryptic Digestion.  To identify the modified site by mechanism-based inhibitor that 
resulted in enzyme inactivation, the enzyme was incubated with phenylhydrazine in 20 mM Tris-
Cl at pH 8 and 20 oC in the presence and absence of 140 mM glycine betaine.  Enzyme activity 
was monitored over time until ~90% of the enzyme became inactivated.  Gel filtration was used 
to remove the excess reagents.  The inactive enzyme was denatured with 10% (w/v) 
trichloroacetic acid and incubated on ice for 30 min before centrifugation at 12000g for 20 min. 
The pellets were washed with 10% trichloroacetic acid followed by an ice-cold acetone/HCl 
(39:1) mixture, resuspended in 0.1 mL of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium 
bicarbonate, pH 8, and allowed to stand for 1 h at 37 C. The solutions were then diluted with 
0.3 mL of water before the addition of trypsin to a final concentration of 3% (w/w, 
trypsin/choline oxidase). After 4 h incubation at 37 C, a second aliquot of trypsin (1% w/w 
final concentration) was added, and the mixture was allowed to react for a further 15 h at 37 C. 
The digestion was stopped with trifluoroacetic acid (1% final concentration). Purification of 
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPD-
M10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column at 
a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous trifluoroacetic acid, and eluent B was 
0.04% trifluoroacetic acid in acetonitrile. The chromatography was carried out with a linear 
gradient from 5% to 50% eluent B over 90 min. Peptide fragments were collected manually.  For 
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the identification of the modified peptide, MALDI-TOF mass spectrometry was used in both the 
positive and negative ion mode with 50:50 methanol/acetonitrile matrix. 
 Data Analysis.  Data were fit with KaleidaGraph software (Synergy Software, Reading, 
PA).  The steady state kinetic parameters were determined by fitting the data to the Michaelis-
Menten equation for one substrate.  Time course of inactivation of choline oxidase was fit with 
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and 
kobs is the observed rate of the inactivation.  Substrate inhibition data was fit to eq (2) (29), where 
v is the velocity of enzyme activity at any concentration S, Vmax′ is the observed maximal 
velocity, [S] is the concentration of the substrate, Km′ is the apparent Michaelis-Menten constant, 
and KI is the dissociating constant of the inhibitor from the enzyme. 
tkeAA obs0
−=    (1) 
2
Im
max
[S][S]
[S]
K'K
'V
v ++=  (2) 
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Results 
 Inactivation of Choline Oxidase with Phenylhydrazine.  When choline oxidase was 
incubated with phenylhydrazine in 20 mM Tris-Cl at pH 8 and 20 oC, a time-dependent loss of 
enzymatic activity was observed (Figure 4.1 panel A).  In the presence of glycine betaine, the 
enzyme remained ~100% active with 0.5 mM phenylhydrazine, suggesting that the enzyme is 
protected from inactivation in the presence of its catalytic product.  As shown in Figure 4.1 panel 
B, the inactivation followed second-order kinetics that is dependent on the concentration of 
phenylhydrazine and yields a kinact value of 0.04 mM-1 min-1.  After inactivated enzyme was 
isolated by gel filtration and was incubated in 20 mM Tris-Cl at pH 8 and 20 oC for three hours, 
no recovery of activity was observed.  This indicated that the inactivation of choline oxidase by 
phenylhydrazine was irreversible.  Phenylhydrazine was also tested as a substrate for choline 
oxidase in 50 mM potassium phosphate at pH 7 and 25 oC.  Significant activity was detected 
with phenylhydrazine concentrations in the range from 5 mM to 40 mM.  The activity of the 
enzyme increased with increasing phenylhydrazine concentration up to 20 mM then gradually 
decreased at concentrations >20 mM, suggesting a substrate inhibition mechanism (29).  The 
data were fit with Equation 2 to yield a kcat of 1.1 ± 0.8 s-1, a Km’ of 34.7 ± 27.8 mM, and a KI of 
8.5 ± 7.2 mM.  The large error obtained from the fitting may due to not enough data points to 
define the curve. 
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Figure 4.1.  Time-dependent inactivation of choline oxidase by phenylhydrazine.  Choline 
oxidase at 0.54 µM was incubated with different concentrations of phenylhydrazine in 20 mM 
Tris-Cl, pH 8, at 20 oC.  Enzyme activity was monitored overtime in 50 mM potassium 
phosphate, pH 7, at 25 oC.  (A) Time course inactivation with phenylhydrazine at (●) 0.5 mM in 
the presence of 1.2 M glycine betaine, (○) 0.1 mM, (■) 0.3 mM, (□) 0.5 mM, (♦) 0.9 mM, (◊) 1.2 
mM, and (▲) 2.0 mM.  (B) The observed rate of enzyme inactivation as a function of the 
concentration of phenylhydrazine. 
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Figure 4.2.  Substrate inhibition behavior of choline oxidase with phenylhydrazine as substrate.  
Enzyme activity was measured in 50 mM potassium phosphate, pH 7, at 25 oC.  The curve is a fit 
of the data to equation (2). 
  
 Properties of Choline Oxidase Modified with Phenylhydrazine.  UV-visible absorbance 
spectrophotometer was used to observe the effect of phenylhydrazine under aerobic conditions 
on the flavin cofactor of choline oxidase in 20 mM Tris-Cl at pH 8 and 15 oC.  As shown in 
panel A of Figure 4.3, the inactivation of the enzyme by phenylhydrazine was associated with 
the bleaching of the 454 nm peak and an increase in absorbance at 370 nm, suggesting the 
formation of flavin semiquinone.  After 2.5 h of incubation, 86% of residual activity was lost and 
67% of oxidized flavin was turned into flavin semiquinone (Figure 4.3 panel B).  The reduced 
form of the enzyme-bound flavin could not be obtained with longer incubation time (up to 30 h) 
or with higher concentrations of phenylhydrazine (up to 2 mM). 
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Figure 4.3.  UV-visible absorbance spectra of the inactivation of choline oxidase at 35.2 µM 
with 0.5 mM phenylhydrazine in 20 mM Tris-Cl, pH 8, at 15 oC.  (A) For clarity, only selected 
UV-visible absorbance spectra were showed; spectra 1 and 10 were recorded at 1 and 150 min of 
incubation, respectively.  (B) Residual activity (●) and absorbance at 455 nm (○); the data were 
fit with equation (1). 
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 Identification of the Site of Modification of Choline Oxidase by Phenylhydrazine.  To 
identify the site of modification by phenylhydrazine that is responsible for the inactivation of 
choline oxidase, the enzyme was inactivated to 20% residual activity.  Excess phenylhydrazine 
was removed by gel filtration.  The sample was digested with trypsin into peptide fragments.  
The peptides were separated by reverse-phase HPLC and compared to the peptides fragment of 
another enzyme sample that was treated with the same concentration of phenylhydrazine but was  
protected by glycine betaine (Figure 4.4).  The two chromatographic maps were similar to each 
other except for the peptides eluted at 44.3 min, 50.9 min, and 60.7 min, which showed a 
significant difference in peak intensity.  These peptides were collected and identified using mass 
spectrometry (Table 4.1).  The results from mass spectrometry showed that the peptide fragments 
eluted at the three elution times were found in both protected and unprotected enzyme sample, 
suggesting no specific modification on the peptides.  However, at 50.9 min, the unprotected 
sample had one extra peak that could not be identified because its mass did not match with any 
of the possible modified or unmodified tryptic digested peptides. 
 
Table 4.1. Mass spectrometry analysis of modified peptides in choline oxidase.a 
Elution time, min 44.3 50.9 60.7 
In the presence (+GB) or in the absence 
(-GB) of glycine betaine 
+GB -GB +GB -GB +GB -GB 
Molecular weight of peptide from mass 
spectrometry analysis, m/z 
1828.8 
1921.8 
2193.0
1828.6 
1921.6 
2191.7
1837.8 1838.6 
1860.5 
3208.0 3207.7
a Data obtained with MALDI-TOF mass spectrometry, using both positive and negative ion 
mode with 50:50 methanol/acetonitrile matrix. 
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Figure 4.4.  Overlaid HPLC chromatograms of tryptic digests of choline oxidase treated with phenylhydrazine in the presence (black 
line) and absence (green line) of glycine betaine.  Peptide elution was monitored at 214 nm with a photodiode array spectrophotometer 
detector.  The peptides eluting at 44.3 min, 50.9 min, and 60.7 min (*) showed a significant difference in peak intensity. 
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Discussion 
 The flavoprotein choline oxidase from Arthrobacter globiformis catalyzes the two steps 
oxidation of a primary alcohol substrate to carboxylate product with an aldehyde intermediate.  
In the absence of crystallographic data, chemical modification was employed in order to identify 
the essential catalytic residues in the active site of choline oxidase.  In this study, 
phenylhydrazine was chosen for the modification study of choline oxidase because it can 
inactivate the enzyme at low concentrations.  The inhibitory mechanism of enzymes by 
phenylhydrazine has also been studied by other authors and understood for other flavoenzymes, 
such as monoamine oxidase (30) and trimethylamine dehydrogenase (31)  Enzyme inactivation 
by phenylhydrazine usually involves the generation of a carbon-centered radical or anion at the 
active site (31, 32).  These species are highly unstable and could react with the cofactors or 
active site residues in the enzyme.   
 The results presented herein show that the inactivation of choline oxidase by 
phenylhydrazine is both time and concentration dependent.  The evidence for this conclusion 
comes from the single exponential decay of enzymatic activity in the presence of 
phenylhydrazine.  The observed rate of inactivation also increased with increasing concentration 
of phenylhydrazine yielding a second-order rate constant, suggesting a reversible inactivation.  
However, there was no recovery of activity when the inactive enzyme was isolated and incubated 
at 20 oC for 3 h.  A likely explanation for these results is that the concentrations of 
phenylhydrazine used to obtain kobs of inactivation are still bellow KI value (the dissociation 
constant of the mechanism-based inhibitor) i. e., larger concentration of phenylhydrazine is 
required to reach kinact.  However, reaching kinact can be difficult to achieve because the 
  
77
observed rate of inactivation of the enzyme with phenylhydrazine >2.0 mM will be too fast to 
measure.  
 The inactivation of choline oxidase is active-site directed, as suggested by the protective 
effect of glycine betaine on the enzyme.  This conclusion is consistent with the fact that 
phenylhydrazine can be used as the substrate of choline oxidase.  These data implied that the 
inactivation of choline oxidase with phenylhydrazine is mechanism-based; the inhibitor is 
required be converted into its reactive form for the inactivation to occur.  However, more data 
are needed to support this interpretation because it is predicted that the flavin peak will be 
bleached reversibly by phenylhydrazine under anaerobic conditions if there is an oxidative 
process of the inhibitor involved, as previously reported for the case with the flavin-dependent 
monoamine oxidase (33).  
 The formation of flavin semiquinone upon incubation with phenylhydrazine is not fully 
responsible for the inactivation of choline oxidase, as suggested by the difference in the 
remaining enzymatic activity and the oxidized form of the enzyme3 after 2.5 h incubation with 
phenylhydrazine.  This is consistent with the involvement of one electron transfer of the flavin in 
the process of enzyme inactivation.  To our knowledge, there was no previously reported 
electron-transfer inhibitory mechanism observed for the case of flavoenzyme with 
phenylhydrazine as the inhibitor.  Instead, phenylhydrazine was well known for inhibition 
involving the generation of the phenyl radical, whose reactivity is nonselective (34).  In fact, it is 
                                                 
3 Earlier study by our group reported the semiquinone form of choline oxidase is insensitive to 
both oxygen and organic substrate, as suggested by the lack of oxygen consumption and the lack 
of change in UV-visible absorbance of the flavin semiquinone in the presence of choline (24).  
Therefore, if the semiquinone formation is fully responsible for the inactivation of choline 
oxidase with phenylhydrazine, the remaining enzymatic activity at the end of incubation should 
be comparable to the amount of oxidized enzyme remained.  That is because the oxidized and 
unmodified-enzyme was the only species that can consume oxygen in the activity assay.  
  
78
very likely that the inactivation process of choline oxidase with phenylhydrazine involving both 
one electron-transfer of the flavin and the nonselective reaction of phenyl radicals with group(s) 
in the active site of the enzyme that participate in catalysis.   This hypothesis can also be used to 
explain the various modification sites found on tryptic map of the inactive enzyme.  
Nevertheless, more data must be obtained in order to prove this hypothesis. 
 We concluded that the chemical modification of choline oxidase using phenylhydrazine 
resulted in nonspecific modification; accounting for the fact of many modifications was found 
but no modification site that responsible for enzyme inactivation was identified.  However, 
modification with higher concentration of phenylhydrazine might be used to reduce the 
interaction time of the inhibitor with the enzyme environment, resulting in more selective 
modification.  Future studies will aim to obtain a more selective modification of choline oxidase 
using phenylhydrazine.  The identification of a residue that is of importance to the catalytic 
mechanism of choline oxidase could be used in future mutagenesis to better understand the 
catalytic strategy of the enzyme. 
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Chapter V 
CHEMICAL MODIFICATION OF CHOLINE OXIDASE WITH 
TETRANITROMETHANE 
 
Abstract 
 Choline oxidase catalyzes the two sequential flavin-linked hydride transfers that convert 
choline to glycine betaine. In this study, the enzyme was irreversibly inactivated with 
tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC.  The inactivation by tetranitromethane 
was both time and concentration dependent.  The rate of inactivation followed saturation 
kinetics, yielding a first-order rate constant (kinact) of 0.32 ± 0.01 h-1, and a dissociation constant 
(KI) of 0.66 ± 0.04 mM, suggesting the inactivation occurred after tetranitromethane bound to the 
enzyme.  The product of the enzyme catalytic reaction, glycine betaine, protected the enzyme 
from inactivation, indicating the inactivation is active-site directed.  UV-visible absorbance of 
both protected and unprotected enzyme sample showed the presence of nitrated tyrosines, but the 
unprotected sample had greater absorbance intensity equivalent to a difference of 5 tyrosines.  
The tryptic maps of protected and unprotected enzyme sample were compared, but the 
modifications by tetranitromethane were found on both enzyme samples; therefore, no specific 
modification site was identified. 
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Introduction 
 Tetranitromethane (TNM) has been used in chemical modification of many proteins since 
1930 (1).  In many cases, incubation with this reagent resulted in the irreversible inactivation of 
the enzyme.  The inactivation may be active-site-directed, as shown by the protective effects of 
competitive inhibitors.  Detailed studies of on the protein modification by tetranitromethane have 
suggested that the reaction of TNM involves the nitration of tyrosyl residues (2, 3).  The reaction 
of tetranitromethane with tyrosyl residue involve the formation of a charge-transfer complex 
with the phenol group of the tyrosine, followed by the generation of the phenoxide and nitrite 
radicals due to electron transfer.  The nitrite radicals reacts with the phenoxide and results in the 
formation of the nitrotyrosine and the release of a nitroformate anion.  Additional reactions are 
possible due to the high reactivity of phenolate radicals with each other.  
 Choline oxidase is a flavin-dependent enzyme with a dimeric structure and a mass of 120 
kDa (4).  The enzyme has gained attention from research field because of its almost unique 
catalytic strategy, which allowed the oxidation of an alcohol and an aldehyde to occur in the 
same active site.  The detail catalytic reaction of choline oxidase is illustrated in Scheme 5.1, 
which involves the oxidation of choline to glycine betaine through two oxidation steps with 
betaine aldehyde as the intermediate and molecular oxygen as the final electron acceptor 
(Scheme 5.1). 
(CH3)3N
+ OH
H2O2
(CH3)3N
+ O
H2O2
O2
(CH3)3N
+ O
O
H2O, O2Choline Betaine aldehyde Betaine  
 
Scheme 5.1.  Reaction catalyzed by choline oxidase. 
 
Other than the interesting catalytic mechanism, choline oxidase was considered of importance to 
both medical and biotechnological applications because the product of its catalytic reaction, 
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glycine betaine.  Glycine betaine is a compatible solute that can be found to accumulated by (5, 
6) human pathogens (7-16) and crop plants (17-22) as a response to dehydration and plasmolysis 
in the environments.  For these reasons, the study of choline oxidase can give insights into 
glycine betaine biosynthesis found in bacterial and plants, enabling the development of drug that 
can target the resistance of human pathogens to the environments on host tissue and for the 
engineering of transgenic plants that carried drought and salt stress resistance. 
 Over the years, our group have reported a number studies on choline oxidase.  Firs, the 
cloning and expression of the gene coding for choline oxidase from A. globiformis strain ATCC 
8010 in E. coli was carried out successfully (4).  Kinetic isotope effect was used to elucidate the 
chemical mechanism for the oxidation of choline catalyzed by choline oxidase (23, 24).  The 
results suggested that the hydride transfer between the α-carbon of the activated alkoxide form 
of choline and the enzyme-bound flavin cofactor occurred quantum mechanically.  The presence 
of an active site base with pKa of ~7.5 was also established based on the data from pH and 
kinetic isotope effects of the kinetic parameters of choline oxidase with choline as substrate (25-
27).  The roles of His466 was characterized when the histidine was replaced with and alanine or 
an asparatate.  Spectroscopic and kinetic properties of H466A and H466D mutants suggested that 
His466 stabilized in the negative charges in the enzyme active site by its imidazolium side chain 
and contributed into the polarity of the microenvironment of the flavin (28, 29).   
  Despite the in depth understanding on the catalytic mechanism of choline oxidase based 
kinetic and mechanistic studies, our investigation on this enzyme is still limited without 3-
dimensional structure.  Consequently, chemical modification of choline oxidase using 
tetranitromethane was used in this study to identify the tyrosine residue that may be essential for 
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catalysis.  Kinetic and structural properties of the inactivation of choline oxidase by 
tetranitromethane were characterized using spectrophotometric and chromatographic techniques.  
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Experimental Procedures 
 Materials and enzyme preparations.  Choline chloride was from ICN Pharmaceutical 
(Aurora, OH). Glycine betaine and tetranitromethane were from Sigma-Aldrich (St. Louis, MO). 
TPCK-treated trypsin was purchased from Worthington (Lakewood, NJ).  Recombinant choline 
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid 
pET/codA1 and purified to homogeneity as described previously (4). Fully oxidized choline 
oxidase was prepared as described in ref. (27), and was stored at -20 oC in either 20 mM Tris-Cl, 
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was 
rapidly thawed on ice prior of each experiment.  The concentration of choline oxidase was 
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4 
mM-1cm-1 (26).  All kinetic parameters determined were expressed per active site oxidized flavin 
content (26). All other reagents were of the highest purity commercially available. 
 Instruments.  Inactivation of enzyme was carried out by incubating the enzyme with the 
inhibitor in Eppendorf Mastercycler model 5333 thermostated at 20 oC. Enzyme activity was 
measured polarographically by monitoring the rate of oxygen consumption with a Hansatech 
oxygen electrode (HansaTech Oxy-32) thermostated at 25 oC.  UV-visible absorbance spectra 
were recorded on a Hewlett-Packard 8453A diode array spectrophotometer.  Purification of 
peptides was carried out by HPLC using a Shimadzu instrument equipped with a model SPD-
M10A photodiode array detector and a µBondapak C18 (15 × 4.6 mm) reverse-phase column. 
 Enzyme assays.  Enzyme activity was measured with the method of the initial rates (30) 
in air-saturated 50 mM potassium phosphate at pH 7 by monitoring the rate of oxygen 
consumption with a computer-interfaced Oxy-32 oxygen-monitoring system  (Hansatech 
Instrument Ltd.) thermostated at 25 oC. The reactions were started by the addition of choline 
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oxidase to a 1 ml reaction mixture.  Unless otherwise stated, the final concentration of enzyme in 
the reaction mixture was in 0.1 to 0.5 µM range, and the concentration of choline was 10 mM.   
The enzyme was inactivated by incubating in the presence of tetranitromethane in 20 mM Tris-
Cl at pH 8 and 20 oC.  At different times, aliquots were withdrawn and assayed polarographically 
for enzymatic activity.  Stock solution of tetranitromethane was prepared in ethanol prior use. 
 Tryptic Digestion.  The enzyme was first incubated with tetranitromethane in the 
presence and absence of 140 mM glycine betaine until there was ~10% of residual activity left in 
the unprotected sample.  The enzyme was isolated from excess TNM by gel filtration.  The 
inactive enzyme was denatured with 10% (w/v) trichloroacetic acid and incubated on ice for 30 
min before centrifugation at 12000g for 20 min. The pellets were washed with 10% 
trichloroacetic acid followed by an ice-cold acetone/HCl (39:1) mixture, resuspended in 0.1 mL 
of 8 M urea, 4 mM CaCl2, and 0.4 M ammonium bicarbonate, pH 8, and allowed to stand for 1 h 
at 37 C. The solutions were then diluted with 0.3 mL of water before the addition of trypsin to 
a final concentration of 3% (w/w, trypsin/choline oxidase). After 4 h incubation at 37 C, a 
second aliquot of trypsin (1% w/w final concentration) was added, and the mixture was allowed 
to react for a further 15 h at 37 C. The digestion was stopped with trifluoroacetic acid (1% final 
concentration). Purification of peptides was carried out by HPLC using a Shimadzu instrument 
equipped with a model SPD-M10A photodiode array detector and a µBondapak C18 (15 × 4.6 
mm) reverse-phase column at a flow rate of 1 mL min-1. Eluent A was 0.05% aqueous 
trifluoroacetic acid, and eluent B was 0.04% trifluoroacetic acid in acetonitrile. The 
chromatography was carried out with a linear gradient from 5% to 50% eluent B over 90 min. 
Peptide fragments were collected manually.  MALDI-TOF mass spectrometry in both the 
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positive and negative ion mode with 50:50 methanol/acetonitrile matrix was used to identify the 
modified peptide. 
 Data Analysis.  Data were fit with KaleidaGraph software (Synergy Software, Reading, 
PA).  The steady state kinetic parameters were determined by fitting the data to the Michaelis-
Menten equation for one substrate.  Time course of inactivation of choline oxidase was fit with 
eq (1), where A represents the residual activity at a given time (t), A0 is the initial activity, and 
kobs is the observed rate of the inactivation.  The rates of inactivation of the enzyme were fit to eq 
(2), where kinact is the first-order rate constant for the conversion of the reversibly formed 
enzyme-inhibitor complex to irreversibly inactivated enzyme, [I] is the concentration of the 
mechanism-based inhibitor, and KI is the dissociation constant of the mechanism-based inhibitor 
from the enzyme.   
tkeAA obs0
−=    (1) 
I
inact
obs ]I[
]I[
K
k
k +=   (2) 
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Results 
 Inactivation of Choline Oxidase with Tetranitromethane.  When choline oxidase was 
incubated with tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC, a time-dependent loss of 
enzymatic activity was observed (Figure 5.1 panel A).  The inactivation was dependent on the 
concentration of tetranitromethane.  When the observed rates of inactivation were plotted as a 
function of the concentration of tetranitromethane (Figure 5.1 panel B), a saturation curve was 
observed, suggesting the inactivation followed first-order kinetics that involved reversible 
binding of tetranitromethane to the enzyme followed by irreversible inactivation of the enzyme.  
The curve was fit with equation 2 to yield a kinact of 0.32 ± 0.01 h-1 and a KI of 0.66 ± 0.04 mM.  
In the presence of glycine betaine, the enzyme was fully protected from inactivation at ≤2.5 mM 
tetranitromethane, but it was only partially protected at >2.5 mM tetranitromethane, suggesting 
that the inactivation might become nonselective at high concentration of tetranitromethane.  No 
activity recovery was detected when the inactivated enzyme was isolated by gel filtration then 
incubated in 20 mM Tris-Cl at pH 8 and 20 oC for 2h.  This is consistent with the inactivation 
choline oxidase by tetranitromethane being irreversible.  To verify that the presence of 
tetranitromethane did not affect the biological function of active choline oxidase, the enzyme 
was inactivated to 30% of residual activity then isolated by gel filtration.  Activity assay of this 
sample yielded  a turn over number (kcat) of 7.6 ± 0.1 s-1, which was equivalent to  ~30% of the 
kcat value of the fully active enzyme, i. e., 18.6 ± 0.6 s-1 (Figure 5.2).  The Michaelis-Menten 
constant (Km) in partially modified and native enzyme samples were 0.61 ± 0.03 mM and 0.63 ± 
0.07 mM, respectively, suggesting that the activity detected was only due to the active form of 
the enzyme in the partially modified sample.  In this context, the data indicated that the partially 
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modified enzyme sample contains a mixture of inactive and active enzymes and that the active 
enzyme in the sample was still functioned normally and was capable of catalysis. 
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Figure 5.1.  Time-dependent inactivation of choline oxidase with tetranitromethane.  Choline 
oxidase at 0.54 µM was incubated with different concentrations of tetranitromethane in 20 mM 
Tris-Cl, pH 8, at 20 oC.  Enzyme activity was monitored over time in 50 mM potassium 
phosphate, pH 7, at 25 oC.  (A) Time course of inactivation at different concentrations of 
tetranitromethane.  For clarity, only data with (●) 0.5 mM, (○) 1.0 mM, (■) 4 mM, and (□) 5 mM 
tetranitromethane are shown.  (B) Secondary plot of the observed rate of inactivation as a 
function of the concentration of tetranitromethane.  The data were fit to equation (2). 
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Figure 5.2.  Activity assay of native (○) and TNM-modified (●) choline oxidase in 50 mM 
potassium phosphate, pH 7, at 25 oC.  The TNM-modified enzyme sample was prepared by 
incubating the enzyme with 5 mM TNM in 20 mM Tris-Cl, pH 8, at 20 oC.  Inactivation of 
enzyme was allowed to occur until 35% of residual activity remained, then excess TNM was 
removed using gel filtration.  The data were fit to Michaelis-Menten equation for one substrate. 
 
 
 Properties of Choline Oxidase upon Inactivation with Tetranitromethane.  The TNM-
modified form of choline oxidase in the presence and absence of glycine betaine was isolated 
with gel filtration and their UV-visible absorbance spectra were compared (Figure 5.3).  Both 
spectra showed a significant increase in absorbance at 360 nm as compared to the spectrum of 
native enzyme, indicating the presence of nitrotyrosines.  However, the TNM-modified sample 
in the absence of glycine betaine has spectrum with larger intensity as compared to that of the 
enzyme sample that was incubated in the presence of glycine betaine, suggesting a different 
amount of modified tyrosine in the enzyme when it was partially protected from inactivation.  
The amount of tyrosine residues being modified was quantitated using the absorbance difference 
between the TNM-treated enzyme and the native enzyme and ε360 = 14 M-1 cm-1 for the nitrated 
tyrosine at 360 nm (2, 31).  The result showed that there was a difference of 5 modified tyrosyl 
residues in TNM-modified enzyme sample in the absence of glycine betaine as compare to the 
TNM-modified sample in the presence of glycine betaine. 
  
93
0
2
4
6
300 400 500 600 700 800
A
bs
or
ba
nc
e
Wavelength, nm
 
Figure 5.3.  UV-visible absorbance spectra of the native form (thin line) and the TNM-modified 
forms of choline oxidase in the presence (dotted line) and in the absence (thick line) of glycine 
betaine.  Both protected and unprotected enzyme samples were incubated with 8 mM 
tetranitromethane in 20 mM Tris-Cl at pH 8 and 20 oC. 
 
 Identification of the Site of Modification of Choline Oxidase by Tetranitromethane.  To 
identify the site of modification by tetranitromethane that might be responsible for the 
inactivation of choline oxidase, the enzyme was inactivated with tetranitromethane to 24% 
residual activity.  Excess tetranitromethane was removed by gel filtration.  The sample was 
digested with trypsin into peptide fragments.  The peptides were separated by reverse-phase 
HPLC and compared to the peptides of another enzyme sample that was treated with the same 
concentration of tetranitromethane but was partially protected by glycine betaine (Figure 5.4).  
The two chromatographic maps at 360 nm contained various differences both in peak intensity 
and position.  The peptides eluting at 31.1 min were collected because the peak at this retention 
time showed the most significant difference.  Mass spectrometric analysis showed that the same 
peptide fragments were found in both protected and unprotected sample (data not shown), 
suggesting nitration at these peptides might not be responsible for the inactivation of choline 
oxidase by tetranitromethane. 
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Figure 5.4.  Overlaid HPLC chromatograms of tryptic digests of choline oxidase treated with tetranitromethane in the presence (black 
line) and absence (green line) of glycine betaine.  Peptide elution was monitored at 360 nm with a photodiode array spectrophotometer 
detector.  The peak that eluted at 31.1 min (*) was collected for mass spectrometry analysis. 
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Discussion 
 The biosynthesis of glycine betaine by choline oxidase is of importance to both medical 
and biotechnological applications because glycine betaine was found to accumulate in beneficial 
plants and bacterial as stress resistance to adverse hyperosmotic environments (7-22).  Over five 
years, detailed studies on kinetics and mechanistic properties of choline oxidase were carried out, 
providing a good understanding on the catalytic mechanism of the enzyme.  However, in the 
absence of crystallographic data, the study on catalytic strategy of choline oxidase at structural 
level was limited.  An alternate approach using chemical modification was employed in order to 
identify essential catalytic residue in the active site of choline oxidase.  In this study, 
tetranitromethane was chosen for the modification study of choline oxidase because it can 
inactivate the enzyme with significant rate.   
 The results presented herein show that the inactivation of choline oxidase with 
tetranitromethane is both time and concentration dependent.  The evidence for this conclusion 
comes from the single exponential decay of enzymatic activity in the presence of 
tetranitromethane.  The observed rate of inactivation increased with increasing concentration of 
tetranitromethane to a limiting value.  This is consistent with the reversible binding of enzyme 
and tetranitromethane occurred before the inactivation of the enzyme.  Evidence for the 
inactivation of the enzyme being irreversible was found when the isolated inactive enzyme was 
incubated at 20 oC and no activity recovery was observed for 3 h.   
 The inactivation of choline oxidase is active-site directed with ≤2.5 mM 
tetranitromethane but is nonselective with >2.5 mM tetranitromethane, as suggested by the 
protective effect of glycine betaine on the enzyme.  The increase in intensity of UV-visible 
absorbance at 360 nm of the TNM-modified enzyme is the evidence for formation of nitrated 
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tyrosine upon inactivation with tetranitromethane.  The fact that the nitration of tyrosine was 
observed in both protected and unprotected enzyme sample can be explained by the fact that 
choline oxidase has 11 tyrosyl residues in its amino acid sequence, so it is likely that tyrosyl 
residues outside the active site have been modified.  Such modification might be responsible for 
the partial inactivation of the enzyme in the presence of a ligand in the active site.  This is 
consistent with the data from UV-visible absorbance spectra, which showed that the unprotected 
enzyme sample has 5 nitrotyrosines more than that found in the protected sample when the 
inactivation was carried out with 8 mM tetranitromethane.   
 Comparison of the tryptic maps of protected and unprotected enzyme sample revealed the 
nonspecific modification of tetranitromethane, as suggested by various differences found on the 
chromatograph at 360 nm.  Since the enzyme was only partially protected at tetranitromethane 
>2.5 mM, the results cannot be improved by using high concentration of tetranitromethane. 
 In conclusion, the chemical modification of choline oxidase using tetranitromethane 
resulted in nonselective modification; therefore, no essential peptide can be identified in this 
study.  Future study will be necessary to obtain a more selective modification of choline oxidase 
using different mechanism-based inhibitor.  The identification of a residue that is of importance 
to the catalytic mechanism of choline oxidase can be used in future mutagenesis to better 
understand the catalytic strategy of the enzyme. 
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Chapter VI 
TRAPPING OF CHOLINE OXIDASE IN A NON-FUNCTIONAL CONFORMATION BY 
FREEZING AT LOW PH 
(A revised version of this chapter has been submitted for publication in Proteins by Hoang, J. V. 
and Gadda, G. on July 2006) 
 
Abstract 
Choline oxidase is a flavin-dependent enzyme that catalyzes the oxidation of choline to 
glycine-betaine, with oxygen as electron acceptor. Storage at pH 6 and -20 oC resulted in a 
change in the conformation of choline oxidase, as suggested by spectroscopic data, which was 
associated with compete loss of catalytic activity when the enzyme was assayed at pH 6. 
Treatment of the inactive enzyme at pH values ≥6.5 and 25 oC resulted in the fast and partial 
reactivation of the enzyme, which occurred within 6 min, resulting in the slow onset of steady 
state during enzymatic turnover. The rate of approaching steady state was independent of the 
concentrations of choline and enzyme, but increased to a limiting value with increasing pH, 
defining a macroscopic pKa value of ~7.3 for an unprotonated group required for enzyme 
activation. Prolonged incubation of the inactive enzyme at pH 6 and temperatures ≥20 oC 
resulted in the slow and full recovery of activity over 3 hours, associated with a conformational 
change that reverted the enzyme to the native form, as suggested by spectrophotometric data. 
The temperature-dependence of the slow enzyme activation at pH 6 yielded ∆H‡ and ∆S‡ values 
of ~112 kJ mol-1 and ~64 J K-1 mol-1, respectively, resulting in an entropy of activation (T∆S‡) at 
25 oC of ~20 kJ mol-1. These data suggest that freezing the enzyme at low pH induces a localized 
and reversible conformational change that is associated with the complete and reversible loss of 
catalytic activity. 
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Introduction 
 For years, freezing has been used extensively for the storage of purified enzymes. In most 
cases, isolated soluble enzymes stored at sub-freezing temperatures and neutral or slightly 
alkaline pH values are found to be stable and maintain catalytic activity, although in some cases 
partial loss of catalytic activity due to the unfolding of the protein may arise during the freezing 
and thawing processes. In a limited number of cases, however, subjecting purified enzymes to 
storage at sub-freezing temperatures results in the reversible loss of catalytic activity not being 
associated with unfolding of the protein, as exemplified by L-amino acid oxidase, phosvitin, and 
glutamate mutase (1-8). In this context, significant deviations of the pH from neutrality in the 
storage buffer have been shown to contribute to inactivation, due to changes either in the 
quaternary structure of the protein or in the ionization of groups that participate in catalysis (9). 
For the documented cases of ovoperoxidase, phosphofructokinase, leucocyte proteinase 3, and 
formyltetrahydofolate synthetase, such pH effects on the catalytic activity of the enzyme have 
been shown to be reversible (9-12). A common manifestation of the reversibility of the 
inactivation process is a slow onset of steady state during enzymatic turnover (10, 12). While 
such a hysteretic behavior is commonly found in allosteric enzymes as a strategy for metabolic 
regulation (13-16), it is not common for other classes of enzymes. During the procedure 
employed to purify choline oxidase, the enzyme showed a significant hysteretic behavior after 
storing at pH 6 and -20 oC (Fan Fan, Prashanthi Menon, Jane V. Hoang, and Giovanni Gadda; 
unpublished observations), a step used to fully oxidize the enzyme-bound flavin4 (18), 
suggesting that the enzyme might be affected by freezing at low pH.  
                                                 
4 The enzyme-bound flavin in choline oxidase as purified is present as a mixture of oxidized 
and anionic flavosemiquinone (17). The fully oxidized enzyme is commonly prepared by 
extensive dialysis at pH 6 and 4 oC over 24 hours, as reported in ref. (18), or by short dialysis at 
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 Choline oxidase (E.C. 1.1.3.17) catalyzes the flavin-mediated two-step oxidation of 
choline to glycine betaine, with betaine aldehyde as intermediate and molecular oxygen as 
electron acceptor (Fig. 1) (19-21). The enzyme is of both biotechnological and medical interest 
since glycine betaine can be accumulated in the cytoplasm of cells to prevent dehydration and 
plasmolysis in adverse hyperosmotic environments (22, 23) in pathogenic bacteria (24-33) and 
transgenic plants (34-39). Consequently, the study of choline oxidase has potential for the 
development of therapeutic agents targeted at the inhibition of glycine betaine biosynthesis and 
for the engineering of drought resistance in economically relevant crops. Furthermore, choline 
oxidase has been extensively used for the development of biosensors to detect choline and 
choline ester derivatives, such as acetylcholine, in serological fluids and foodstuff (40-44). The 
enzyme is a homodimer of 120 kDa, with each monomer containing covalently bound FAD (17). 
The chemical mechanism for the oxidation of choline catalyzed by choline oxidase has been 
recently elucidated using kinetic isotope effects, and is consistent with the quantum mechanical 
transfer of a hydride from the substrate α-carbon to the enzyme-bound flavin cofactor occurring 
from an activated alkoxide form of choline (45, 46). Such an alkoxide species has been proposed 
to form by the action of an active site base with pKa of ~7.5 (18, 47, 48), and to be 
electrostatically stabilized in the enzyme active site by the imidazolium side chain of His466 (49, 
50). In the present study, we have investigated the effect of storage temperature and pH on the 
biophysical and catalytic properties of choline oxidase. The results of these studies suggest that 
freezing the enzyme at low pH induces a localized and reversible conformational change that is 
associated with the complete and reversible loss of enzymatic activity. 
                                                                                                                                                             
pH 6 and 4 oC over 3 to 5 hours, followed by storage at pH 6 and -20 oC (Fan Fan, Prashanthi 
Menon, Jane V. Hoang, and Giovanni Gadda; unpublished observations). 
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Experimental Procedures 
 Materials and enzyme preparations.  Choline chloride was from ICN Pharmaceutical 
(Aurora, OH). Glycine betaine was from Sigma-Aldrich (St. Louis, MO). Recombinant choline 
oxidase from Arthrobacter globiformis strain ATCC 8010 was expressed from plasmid 
pET/codA1 and purified to homogeneity as described previously (17). Fully oxidized choline 
oxidase was prepared as described in ref. (18), and was stored at -20 oC in either 20 mM Tris-Cl, 
pH 8, or 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6. The enzyme was 
rapidly thawed on ice prior of each experiment. When needed, buffers were changed either by 
gel filtration through disposable PD-10 desalting columns (Amersham Pharmacia Biotech, 
Piscataway, NJ) or dialysis for 19 h at 4 oC. The concentration of choline oxidase was 
determined spectrophotometrically at 454 nm using the previously reported ε454 value of 11.4 
mM-1cm-1 (48).  All kinetic parameters determined were expressed per active site oxidized flavin 
content (48). All other reagents were of the highest purity commercially available. 
 Instruments.  UV-visible absorbance spectra were recorded using an Agilent 
Technologies diode-array spectrophotometer Model HP 8453; fluorescence spectra were 
acquired on a Shimadzu spectrofluorometer model RF-5301; circular dichroic spectra were 
determined using a Jasco J-180 spectropolarimeter. Time-courses of oxygen consumption were 
determined polarographically with an oxygen electrode from Hansatech Instruments Ltd. 
(Norfolk, UK). 
 Spectral studies.  Absorbance, fluorescence, and circular dichroic spectra were 
determined in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, pH 6, at 15 oC. The 
concentration of enzyme in flavin content was: 11 µM for the UV-visible absorbance spectra, 3 
µM for the protein fluorescence emission spectra (with λex at 285 nm), 11 µM for the flavin 
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fluorescence emission (with λex at ~455 nm), and 2.5 µM, 50 µM, and 168 µM for the CD 
spectra of the protein in the far-UV, near-UV, and visible regions of the spectra, respectively. 
 Enzyme assays.  Unless otherwise stated, time-courses of oxygen consumption and 
enzymatic activity were determined polarographically by measuring the rate of oxygen 
consumption using a computer-interfaced oxygen electrode system in air-saturated 50 mM 
potassium phosphate, at pH 7 and 25 oC. The determination of the kinetic parameters of choline 
oxidase was carried out using the method of the initial rates (51), with concentrations of choline 
in the range from 0.1 to 10 mM. For the determinations at pH 8 and 9, 50 mM sodium 
pyrophosphate was used as buffer. For the enzyme species showing slow onsets of steady state 
during turnover, rates of oxygen consumptions were determined from the linear portions of the 
traces, i.e., after steady state was achieved. 
 Effect of pH on hysteresis.  For the determination of the pH effects on the fast rate of 
reactivation of choline oxidase (kc), the activity of the enzyme species with hysteretic behavior 
was measured in 50 mM Tris (hydroxymethyl) aminomethane with the pH in a range from 6.5 to 
9.6 at 25 oC. 
 Effect of temperature on reactivation of choline oxidase at pH 6.  The temperature 
effects on the slow rate of activation of choline oxidase (kact) were determined by incubating the 
inactive enzyme in the range from 20 to 39 oC at pH 6, and the activity was measured in 50 mM 
morpholinoethansulfonic acid, at pH 6 and 25 oC. 
 Data analysis.  Data were fit with KaleidaGraph software (Biosoft, Cambridge, UK). The 
steady state kinetic parameters were determined by fitting the data to the Michaelis-Menten 
equation for one substrate. The first-order rate constants for the fast and pH-dependent activation 
of the inactive form of choline oxidase  (kc) were determined by fitting the time-courses of 
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oxygen consumption to eq 1, which was modified from Frieden (16), where vf represents the 
observed rate of reaction after reaching steady state, and [O2]o is the initial concentration of 
oxygen. The pH dependence of kc was determined by using eq 2, which describes a curve with a 
slope of +1 and a plateau region at high pH where C represents the pH-independent value. The 
apparent rates of activation of the enzyme at any given temperature were determined by fitting 
the observed rates of oxygen consumption at any given incubation time with eq 3 that describes a 
single exponential process. Here, appkact is the apparent first-order rate constant for the 
temperature-dependent slow activation of the inactive form of choline oxidase, t is time, At is the 
value of enzymatic activity, Ao is the amplitude of the total change, and A∞ is the enzymatic 
activity at infinite time. The temperature dependence of kact was determined by using the Eyring's 
equation (eq 4), where kact is the first-order rate constant for enzyme activation, kB and h are the 
Boltzmann and Planck constants, T is the absolute temperature in Kelvin, R is the gas constant 
with a value of 8.315 J mol-1 K-1, and ∆H‡ and ∆S‡ are the enthalpy and entropy of activation, 
respectively. 
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Results 
 Effect of storage pH and temperature on the enzymatic activity of choline oxidase.  
Storage of the enzyme at pH 6 and -20 oC resulted in a choline oxidase form that was devoid of 
enzymatic activity at pH 6 and 25 oC, as suggested by the lack of oxygen consumption over 
extended incubation of the enzyme with 1 mM choline in 50 mM potassium phosphate, pH 6. In 
contrast, this enzyme form slowly regained enzymatic activity with 1 mM choline at pH 7 and 25 
oC, with a significant hysteretic behavior that was apparent as a slow onset of steady state during 
enzymatic turnover (Figure 6.1). 
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Figure 6.1.  Time-courses of oxygen consumption during turnover of choline oxidase at a final 
concentration of 0.54 µM with 1 mM choline as substrate in air-saturated 50 mM potassium 
phosphate, pH 7, at 25 oC. Solid curve represents the trace using choline oxidase previously 
stored at pH 8 and -20 oC; dashed curve is the trace using choline oxidase previously stored at 
pH 6 and -20 oC. E indicates the time at which the enzyme was added to the assay reaction 
mixture. Thin lines represent the tangents to the linear portions of the trace obtained with choline 
oxidase previously stored at pH 6 and -20 oC. 
 
Significant lags in catalytic turnover were also observed when the enzyme was flash-frozen in a 
mixture of dry ice and acetone at pH 6. In contrast, no lag in the time-courses of oxygen 
consumption was observed when the enzyme was stored at pH 6 and 0 oC or at pH 8, irrespective 
of whether the storage temperature was -20 oC or 0 oC. Similarly, no hysteretic behavior was 
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seen when the enzyme was stored at pH 6 and -20 oC or -80 oC in the presence of 30 or 50% 
glycerol as anti-freezing agent, or when choline oxidase was kept on ice for as long as 26 h. 
These data suggest that freezing of choline oxidase at low pH results in a form of enzyme with 
altered catalytic properties (E'). 
 To evaluate whether the presence of a ligand in the active site of the enzyme affected the 
formation of E', choline oxidase was frozen at pH 6 in the presence of 0.14 M glycine betaine, 
which resulted in ~90% of the enzyme being in a glycine betaine-complex at this pH (48, 50). 
The time-courses of oxygen consumption of the enzyme stored in the presence of glycine betaine 
showed hysteretic behavior (data not shown), suggesting that the altered E' form of choline 
oxidase could be formed irrespective of whether the enzyme was in the free or liganded form.  
 Kinetic parameters of choline oxidase stored at pH 6 and -20 oC.  The turnover number 
(kcat) and the Michaelis-Menten constant (Km) for choline as substrate for the enzyme previously 
stored at pH 6 and -20 oC were determined in 50 mM potassium phosphate, at pH 7 and 25 oC, 
and were compared to those determined for the enzyme that did not show hysteretic behavior 
(E), which was prepared in three different ways by storing choline oxidase at pH 6 or 8 and 0 oC, 
or at pH 8 and -20 oC. As shown in Table 6.1, E' showed a kcat value that was 3-times lower than 
the value determined for E, and a Km value that was similar to that determined for E. Kinetically, 
these data suggest that the altered form of choline oxidase prepared by freezing at pH 6 was 
devoid of enzymatic activity, and that upon reaching steady state at pH 7 and 25 oC the enzyme 
existed as a mixture of the fully active form E that is responsible for the consumption of oxygen 
(~30%) and the inactive form E'. Similar results with kcat values that were ~30% of the value 
determined for the native enzyme and Km values that were similar to those of the native enzyme 
were observed with the altered form of choline oxidase at pH 8 and 9 (data not shown), 
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suggesting that only 30% of the inactive enzyme could regain activity within the time required 
for the oxygen electrode recordings (3 to 6 min). 
 
Table 6.1.  Kinetic parameters of choline oxidase stored at pH 6 and -20 oC with choline as 
substrate at pH 7 and 25 oC. a 
storage pH storage temperature, oC kcat, s-1 Km, mM      L  b, s 
6 -20 4.4 ± 0.1 0.7 ± 0.1 30 – 70 
6 0 13.3 ± 0.2 0.5 ± 0.1 nd c 
8 0 14.9 ± 0.2 0.6 ± 0.1 nd 
8 -20 15.5 ± 0.1 0.6 ± 0.1 nd 
aThe enzymatic activity of choline oxidase that was previously stored at the pH and temperature 
indicated was measured at varying concentrations of choline in air-saturated 50 mM potassium 
phosphate, pH 7, at 25 oC. 
bL represents the length of the lag phase observed before the rate of oxygen consumption reached 
steady state.  
c nd, not detectable. 
 
 Effect of choline and enzyme concentrations on hysteresis.  The effect of choline 
concentration on the hysteretic behavior of choline oxidase under turnover was determined with 
the E' form of enzyme at a final concentration of 0.54 µM, in air-saturated 50 mM potassium 
phosphate, pH 7 and 25 oC. Fitting of the time-courses of oxygen consumption obtained with 
choline concentrations in the 0.5 to 8 mM range by using eq 1 yielded first-order rate constants 
for the attainment of steady state (kc) that were independent of choline concentration (Table 6.2), 
with an average value of 0.017 ± 0.001 s-1. In contrast, the time required to reach steady state, 
i.e., lag time, decreased with increasing concentrations of choline and reached a limiting value of 
~30 s, consistent with the apparent length of the lag phase in catalysis being inversely dependent 
on substrate concentration (Table 6.2). 
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 The effect of enzyme concentrations in the range from 1.1 to 2.8 µM on the hysteretic 
behavior of choline oxidase was also determined with 1 mM choline as substrate at pH 7 and 25 
oC. As summarized in Table 6.2, the kc values were similar to each other and, most importantly, 
were not significantly different from the average kc value determined at varying concentrations 
of choline. As for the case of choline, the apparent length of the lag phase in catalysis was 
inversely dependent on the enzyme concentration, with shorter lags seen at increasing 
concentrations of choline oxidase. Finally, no differences in the length of the lag phase preceding 
steady state were observed in the time-courses of oxygen consumption in assay reaction mixtures 
at pH 7 and 25 oC containing KCl at concentrations as high as 180 mM (data not shown), 
suggesting that the activation of the E' form of choline oxidase did not depend on the ionic 
strength of the solvent.  
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Table 6.2.  Effect of enzyme and substrate concentrations on hysteresis at pH 7 
and 25 oC. a 
E', µM [choline], mM Lb, s vfc, µM s-1  kcc, s-1 R2 
0.54 0.5 54 0.83 ± 0.01 0.015 ± 0.001 0.9997 
0.54 2.0 42 1.30 ± 0.01 0.015 ± 0.001 0.9995 
0.54 4.0 42 1.40 ± 0.01 0.018 ± 0.001 0.9999 
0.54 6.0 36 1.65 ± 0.01 0.016 ± 0.001 0.9997 
0.54 8.0 30 1.40 ± 0.01 0.016 ± 0.001 0.9998 
1.10 1.0 48 1.28 ± 0.01 0.013 ± 0.001 0.9996 
1.66 1.0 42 1.88 ± 0.01 0.012 ± 0.001 0.9994 
2.20 1.0 36 1.93 ± 0.01 0.015 ± 0.001 0.9994 
2.76 1.0 30 2.23 ± 0.01 0.016 ± 0.001 0.9993 
a Time-courses of oxygen consumption during turnover of choline oxidase 
previously stored frozen at pH 6 at the final concentrations indicated (E') with 
choline in 20 mM Tris-Cl, pH 7 and 25 oC, were fit to eq 1.  
b L is the lag in catalytic turnover, i.e., the time required to the enzyme to reach 
steady state conditions.  
 c vf represents the observed rate of reaction after reaching steady state; kc is the 
first-order rate constant for approaching steady state. 
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 Effect of pH on hysteresis.  The effect of pH on the hysteretic behavior of choline 
oxidase was determined in the range from 6.5 to 9.6 at fixed concentrations of choline as 
substrate for choline oxidase and 25 oC. The substrate concentration was set equal to the Km 
value at each pH, in order to avoid artifactual contributions arising from the dependence of the 
length of the lag phase that precedes steady state on the concentration of choline5. The kc values 
were determined at each pH value by fitting the time-courses of oxygen consumption to eq 1. 
The log kc value increased to a limiting value with increasing pH, yielding a pKa value of 7.3 ± 
0.1 for a group that must be unprotonated for activation of the enzyme (Figure 6.2).  
-2.5
-2
-1.5
-1
6 7 8 9 10
lo
g 
k c
, s
-1
pH
 
Figure 6.2. pH dependence of the first-order rate constant for approaching steady state (kc) of 
choline oxidase previously stored at pH 6 and -20 oC. Enzymatic activity was determined with 
choline at concentrations set equal to the Km values with 0.54 µM enzyme in 50 mM potassium 
phosphate at 25 oC. kc values were determined by fitting the time-courses of oxygen consumption 
to eq 1. The curve is a fit of the data to eq 2. 
 
 Spectral properties of choline oxidase stored at pH 6 and -20 oC.  In order to evaluate 
whether protein structural changes were associated with the different catalytic behavior of 
choline oxidase upon freezing at pH 6, the CD, absorbance, and fluorescence properties of E' 
                                                 
5 Choline concentrations that were equal to Km were chosen, instead of saturating 
concentrations, because at high pH and saturating concentrations of choline as substrate for the 
enzyme the lengths of the lag phases were too short in order to obtain accurate data. 
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were determined at pH 6 and 15 oC and compared to those of E. As shown in Figure 6.3A, the 
far-UV CD spectra of E' and E were virtually indistinguishable, consistent with both forms of 
choline oxidase being folded with similar contents in secondary structure elements. However, the 
UV-visible absorbance spectrum of E' showed a 9 nm hypsochromic shift of the peak centered at 
366 nm and a 4 nm bathochromic shift of the band at 457 nm, both associated with significant 
decreases in intensities, with respect to the absorbance spectrum of E (Figure 6.3B). Both the 
protein and flavin fluorescence emission bands at ~340 nm and ~525 nm were two- to three-
times more intense in the spectra of E' compared to E (Figure 6.3C-D). Furthermore, a 
significant bathochromic shift in the near-UV CD spectrum of E' was observed in the 270 to 290 
nm region of the spectrum with respect to that of E (Figure 6.3E). Finally, an inversion of the 
polarity in the visible dichroic band in the 450 nm region of the CD spectrum of the enzyme-
bound flavin was observed upon comparing the visible CD spectra of E' and E, as shown in 
Figure 6.4F. These data suggest that upon freezing the enzyme at low pH, choline oxidase 
undergoes a change in its conformation that significantly affects the flavin microenvironment. 
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Figure 6.3. Determination of the apparent rate of activation of choline oxidase previously stored 
at pH 6 and -20 oC. The E' form of choline oxidase was incubated in 20 mM sodium phosphate, 
20 mM sodium pyrophosphate, pH 6 and 25 oC, over 160 min. At different time intervals, 
aliquots of the enzyme solution were assayed for enzymatic activity with 1 mM choline as 
substrate in 50 mM 2-morpholinoethanesulfonic acid, pH 6 and 25 oC. Panel A, selected time-
courses of oxygen consumption, where curves 1 and 6 represent the traces acquired after 2 and 
72 min of incubation. Panel B, plot of the enzymatic activity as a function of incubation time for 
the determination of the first-order apparent rate constant for activation of choline oxidase by 
using eq 3. 
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 Effect of temperature on activation of the E' form of choline oxidase at pH 6.  The 
effect of temperature on the rate of activation of choline oxidase previously stored at pH 6 and -
20 oC was determined at pH 6 with 1 mM choline as substrate. At this pH value, the first-order 
rate constant for the fast conversion of E' to E (kc) was expected to be sufficiently slow (Figure 
6.2) to affect minimally the time-course of oxygen consumption, thereby simplifying the analysis 
of the data. As expected, the time-courses of oxygen consumption did not show any lag before 
enzyme turnover reached steady state (Figure 6.4A). Moreover, as illustrated in the example of 
Figure 6.4 for the data at 25 oC, the rates of oxygen consumption increased to a limiting value 
that was similar to the value of ~5 s-1 obtained with 1 mM choline as substrate for the native 
enzyme with increasing time of incubation of the enzyme, yielding apparent rates for the slow 
temperature-dependent activation of the enzyme (appkact) at any given temperature (Table 6.3).  
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Figure 6.4. Temperature dependence of the first-order rate constant for activation of choline 
oxidase (kact) in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6. The data 
were fit to eq 4. 
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Table 6.3.  Effect of temperature on the rate of reactivation of choline oxidase at pH 6.a 
temperature, oC appkact x 1,000 b, s-1 kden x 1,000 c, s-1 kact x 1,000 d, s-1 
20 0.17 ± 0.01 0.04 ± 0.01 0.21 ± 0.01 
25 0.47 ± 0.02 0.08 ± 0.01 0.55 ± 0.02 
30 1.03 ± 0.11 0.04 ± 0.01 1.07 ± 0.11 
33 1.87 ± 0.40 0.11 ± 0.01 1.98 ± 0.41 
35 1.40 ± 0.22 0.28 ± 0.03 1.68 ± 0.22 
37 2.50 ± 0.39 0.40 ± 0.06 2.90 ± 0.39 
39 3.61 ± 1.17 0.53 ± 0.06 4.14 ± 1.17 
a Enzymatic activity was determined with 1 mM of choline and 0.54 µM  of enzyme in 50 mM 
air-saturated 2-morpholinoethanesulfonic acid, pH 6, at 25 oC. 
b Measured rate of enzyme activation upon incubation of the E' form of enzyme at the indicated 
temperature. 
c Observed rate of activity loss upon incubation of the fully active enzyme at the indicated 
temperature. 
d True rate of enzyme activation, obtained by adding the rate of activity loss kden to the measured 
rate of enzyme activation, appkact. The standard deviation for each of the kact values was calculated 
from the square root of the sum of the squares of the standard deviations associated with kden and 
appkact. 
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The contribution of enzyme denaturation ensuing from the prolonged incubations at high 
temperatures was taken into account by measuring the first-order rate constant for the loss of the 
enzymatic activity (kden) of the fully active E form of choline oxidase (Table 6.3). These values 
were then added to the appkact values in order to determine the true first-order rate constants for 
the activation of the E' form of choline oxidase in the temperature range from 20 to 39 oC (Table 
6.3). An analysis of the kact value according to the Eyring's formalism yielded a ∆H‡ value of 112 
± 7 kJ mol-1 and a ∆S‡ value of 64 ± 7 J K-1 mol-1 (Figure 6.5). These data are consistent with a 
T∆S‡ value of 19 ± 2 kJ mol-1 and a ∆G‡ value of ~93 kJ mol-1 for the activation barrier for the 
conversion of E' to E at 25 oC. Such a small entropic contribution is consistent with the 
conformational change that is associated with the activation of the enzyme being localized rather 
than global. 
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Figure 6.5. Temperature dependence of the first-order rate constant for activation of choline 
oxidase (kact) in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6. The data 
were fit to eq 4. 
 
 As shown in Figure 6.6, incubation of the E' form of choline oxidase at pH 6 and 25 oC 
resulted in changes in the UV-visible absorbance spectrum of the enzyme, which slowly 
converted to that of the native form of choline oxidase. From the increase in absorbance at 385 
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nm associated with this process, an apparent first-order rate for the conversion of E' to E of (3.3 
± 0.3) x 10-4 s-1 was determined (Figure 6.6inset). The spectrophotometric changes observed 
suggest that the enzymatic activation of the altered form of choline oxidase is associated with a 
change in the conformation of the enzyme. 
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Figure 6.6. Conversion of the E' form to E form of choline oxidase. The E' form of choline 
oxidase was incubated in 20 mM sodium phosphate, 20 mM sodium pyrophosphate, at pH 6 and 
25 oC, and UV-visible absorbance spectra were recorded over 180 min. Only selected spectra at 
different times of incubation minus the initial spectrum of the E´ form are shown; 1 and 6 refer to 
the difference spectra at 12 and 180 min of incubation. Inset, time-course of absorbance increase 
at 385 nm. Data were fit to eq 3. 
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Discussion 
 Choline oxidase is reversibly inactivated by freezing at pH 6. Evidence supporting this 
conclusion comes from the lack of oxygen consumption when the enzyme previously stored at 
pH 6 and -20 oC was assayed with choline as substrate at pH 6 and 25 oC. Upon raising the pH of 
the assay reaction mixture to values ≥6.5 the enzyme was slowly reactivated, as shown by the 
appearance of a detectable lag in the establishment of steady state during turnover with choline. 
Similar lags were also observed upon flash-freezing choline oxidase at pH 6 and -80 oC. In 
contrast, no lags in the time-course of oxygen consumption were observed upon storing the 
enzyme at pH 6 on ice or at sub-freezing temperatures in the presence of the anti-freezing agent 
glycerol. Furthermore, storage of the enzyme at pH 8 did not produce the altered catalytic 
behavior, irrespective of whether the temperature was 0 oC or -20 oC, indicating that inactivation 
of the enzyme results from the synergistic action of sub-freezing temperature and low pH. 
Similar effects of freezing on the catalytic activity of enzymes have been previously reported for 
a limited number of cases, such as L-amino acid oxidase (1, 5-8), glutamate mutase (4), and 
phosvitin (2). 
 From a biophysical standpoint, treatment of the enzyme at pH 6 and -20 oC induces a 
change in the conformation of choline oxidase, which is associated with the loss of catalytic 
activity. Evidence supporting a conformational change of the enzyme comes from the UV-visible 
absorbance, protein and flavin fluorescence emission, and near-UV and flavin circular dichroic 
spectra of choline oxidase after storage at -20 oC and pH 6, all showing significant differences 
with respect to the spectra of the enzyme stored at pH 8. In this respect, the altered conformation 
of the enzyme is not due to denaturation of the protein, since the far-UV circular dichroic 
spectroscopic analysis showed that the altered form of choline oxidase (E') maintains an overall 
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fold similar to that of the native enzyme. The circular dichroic spectrum of the flavin bound to 
the E' form of choline oxidase independently suggests that the enzyme is not denatured, since no 
circular dichroic features are expected for a flavin once it is extracted from the protein 
microenvironment (52). Mechanistically, the molecular motions that are required for the change 
in the conformation of choline oxidase might occur in the rigidity of the ice lattice, for which 
movements of photons, electrons, and protons for molecular reactions in frozen systems have 
been previously established (53-56). Alternatively, the change in the conformation of choline 
oxidase might occur during the freezing process in which the ice crystals are in the process of 
being formed (55-57), as previously proposed for phosvitin (2). Irrespective of whether the 
conformational change occurs in the frozen state or during the freezing process, such a structural 
change results in a conformation of choline oxidase that is not catalytically competent, as 
suggested by the lack of oxygen consumption with choline as substrate at pH 6 and 25 oC. The 
kinetic parameters determined at pH 7 for the partially reactivated enzyme previously frozen at 
low pH, with a lower kcat and a similar Km with respect to the native enzyme, provide 
independent evidence that E' is devoid of enzymatic activity, since these results are readily 
explained with the enzyme during steady state turnover at pH 7 existing as a mixture of fully 
active (E) and inactive forms (E'). 
 Treatment of the inactive E' form of choline oxidase at pH values ≥6.5 and 25 oC results 
in the pH-dependent reactivation of ~30% of the enzyme, through a first-order kinetic process 
that occurs within the time frame of the oxygen electrode recordings (3 to 6 min). Evidence for 
this conclusion comes from the observed slow onsets of steady state when the E' form of the 
enzyme turned over with choline, as illustrated in the example of Figure 6.1. Consistent with 
reactivation of the enzyme being a first-order process, the apparent rate constant for reaching 
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steady state kc was independent of the concentrations of both the enzyme and the choline 
substrate6. Furthermore, the kcat and Km values determined at pH 7, 8, and 9, for the enzyme 
previously frozen at pH 6 clearly suggest that only ~30% of the inactive enzyme could be 
reactivated within minutes through this pH-dependent process. A protein group with an apparent 
pKa of ~7.3 that must be unprotonated is involved in the activation of the altered form of choline 
oxidase, as suggested by the pH-profile of the first-order rate constant kc for reaching steady state 
during enzyme turnover. The slow pH-dependent reactivation of the inactive form of choline 
oxidase, along with the requirement of sub-freezing temperatures and low pH for the inactivation 
of the enzyme, strongly suggest that the reversible loss of enzymatic activity is due to the 
incorrect ionization of one or more protein groups that are not readily accessible to the solvent. 
In this respect, inactivation of the enzyme occurs irrespective of whether the enzyme is in the 
free form or in complex with glycine betaine, consistent with the ionizable group(s) responsible 
for the loss of catalytic activity not being in the active site of the enzyme. Similar reversible 
inactivations of enzymes being due to the incorrect ionization of protein groups have been 
previously proposed for ovoperoxidase (10), phosphofructose kinase (11), formyltetrahydrofolate 
synthetase (9), and leukocyte proteinase 3 (12). 
 The spectral perturbations induced in the UV-visible absorbance spectrum of choline 
oxidase upon freezing at low pH, with a prominent decrease in the intensity at 385 nm with 
respect to the native enzyme, resembled, although they were not identical to, those observed 
upon increasing pH with both the native and the active site variant His466Ala of the enzyme (49). 
                                                 
6 The length of the lag time required to reach steady state during enzymatic turnover of the 
altered choline oxidase was inversely proportional to the concentrations of both choline and 
enzyme. This is due to the rate of oxygen consumption at sub-saturating concentrations of 
choline increasing with both [choline] and [enzyme], and the rate constant for reaching steady 
state (kc) being a first-order rate constant that is independent of both [choline] and [enzyme]. 
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The spectral perturbations with those enzymes were interpreted as arising from the deprotonation 
of the N(3) locus of the enzyme-bound oxidized flavin (58). However, such a flavin position 
must be readily accessible to the solvent, as suggested by the observation that the spectral 
perturbations induced by pH in the native enzyme and the His466Ala variant occur rapidly, ruling 
out a direct change in the ionization state of FAD as being responsible for the loss of enzymatic 
activity in choline oxidase. Nonetheless, the change in ionization state of the group that is 
responsible for the loss of enzymatic activity in choline oxidase has a direct effect on the spectral 
properties of the flavin, suggesting that such an ionizable group is either close to the flavin or 
linked to the flavin through a number of weak interactions, such as hydrogen bonds or salt 
bridges. Independent evidence that the conformational change induced in choline oxidase by 
freezing at low pH affects the microenvironment of the flavin comes from the both the 4 nm 
bathochromic shift of the band at 457 nm and the three-fold increase in flavin fluorescence, both 
consistent with an increased hydrophobicity of the flavin microenvironment in the inactive form 
of choline oxidase compared to the native enzyme (58). 
 At pH 6, the reactivation of the inactive form of choline oxidase is too slow to be seen 
within the time required for the acquisition of the oxygen traces, as suggested by the kc value of 
~3 x 10-3 s-1 estimated from the pH studies. Indeed, at this pH the enzyme did not show any 
oxygen consumption with 1 mM choline. However, prolonged incubation over 180 min of the 
inactive form of choline oxidase at pH 6 and 25 oC resulted in the slow and complete activation 
of the enzyme following a first-order process with a rate constant of activation kact of ~4.7 x 10-4 
s-1. Evidence supporting the conclusion that the enzyme was slowly converted to the active form 
comes from the rate of oxygen consumption of ~4.5 s-1 with 1 mM choline determined after 180 
min of incubation, which was similar to the rate of oxygen consumption of ~5 s-1 observed under 
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the same conditions with the native enzyme. The slow activation of choline oxidase was closely 
associated with a conformational change that reverted the enzyme to the native form, as 
suggested by the UV-visible absorbance spectral changes observed upon incubating the altered 
form of choline oxidase at pH 6 and 25 oC. Such spectral changes occurred according to a first-
order kinetic pattern with a rate constant of ~3 x 10-4 s-1, which is in reasonable agreement with 
the kact value of ~5 x 10-4 s-1 determined for the rate of enzyme activation under the same 
conditions7, consistent with the conformational change being closely associated with the gain in 
enzyme activity. Such a change in the conformation of the enzyme is likely localized, as 
suggested by the small and positive entropy of activation (T∆S) calculated at 25 oC from the 
experimental data, with a value of ~20 kJ mol-1. For comparison, a larger T∆S value of ~90 kJ 
mol-1 was estimated at 25 oC for the pH-dependent reactivation of formyltetrahydrofolate 
synthetase, which was associated to a large conformational change accompanying the formation 
of the active tetramer from the inactive monomers of the enzyme (9).  
 In conclusion, the kinetic and spectroscopic data presented in this study are consistent 
with a localized conformational change in choline oxidase that is associated with the change in 
the ionization state of one or more protein groups, which is induced by freezing at low pH. The 
slow reactivation of the enzyme required elevated temperatures and was facilitated by high pH, 
suggesting that fairly drastic conditions are required to enable the enzyme "locked" in the 
inactive conformation to revert to the native form. Although the groups responsible for the 
                                                 
7 The two rates reported here are not rigorously the same. However, some inaccuracies in the 
determination of the rate of activity increase for the altered form of enzyme can be envisioned 
due to the instability of the enzyme at 25 oC for 180 min. In this respect, the stability of the 
altered enzyme was established by following the decrease in activity of the native enzyme under 
the same conditions, with the assumption that the native and altered forms of choline oxidase 
share the same stability. Since the two forms of enzymes have different conformations, as 
established in this study, they might also have slightly different stability. 
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change in the protein conformation are not readily accessible to the solvent, and therefore are not 
likely to be in the enzyme active site, they have a direct effect on the microenvironment of the 
enzyme-bound flavin and the activity of the enzyme. While the basis for this phenomenon and its 
relationship to the mechanism of the reaction are not fully understood at a molecular level, this 
study shows that localized structural changes trap choline oxidase in a non-functional folded 
conformation that has reversibly lost the ability to catalyze the oxidation of choline. 
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Chapter VII 
GENERAL DISCUSSION 
 
Choline oxidase from Arthrobacter globiformis is one of the rare flavin-dependent 
enzymes that are capable of catalyzing the four electron-oxidation of choline to glycine betaine 
within the same active site (1-3).  Other than the interesting catalytic strategy, the enzyme was 
also studied due to its importance to the biotechnological and biomedical research.  Early studies 
showed that glycine betaine was found to accumulate in the cytoplasm of cells in pathogenic 
bacteria (4-13) and transgenic plants (14-19) as a resistance for dehydration and plasmolysis in 
adverse hyperosmotic environments (20, 21).  The understanding of the catalytic mechanism of 
choline oxidase gives insights into the biosynthesis pathway of glycine betaine found in human 
pathogens and economically relevant crop plants thereby provides foundations for drug 
development that can inhibit the stress resistance of pathogenic bacterial in human tissue or for 
bioengineering of transgenic plants with stress resistance to drought and salt stress.  In this study, 
the chemical modification of choline oxidase with phenylhydrazine or tetranitromethane was 
performed with an attempt to identify the residues that are significant to the catalysis.  Enzyme 
inactivation due to freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at 
pH 6 and -20 oC was also investigated as a measure of how storage conditions can affect the 
biochemical properties of choline oxidase.    
Seven reagents were tested as inhibitors for choline oxidase, including 2-hydrazino-
N,N,N-trimethyl-2-oxopethanaminium, allyltrimethylammonium, isonicotinic acid hydrazide, 3-
dimethylamino-1-propyne, trans-2-phenylcyclopropylamine, phenylhydrazine, and 
tetranitromethane.  The choice of reagents stemmed from previous studies, in which these 
compounds were reported to inhibit enzymes to significant extend and were successfully used in 
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modifying the active site of the enzyme.  The resulted showed that only trans-2-
phenylcyclopropylamine, phenylhydrazine, and tetranitromethane inactivated choline oxidase 
significantly in 20 mM Tris-Cl at pH 8 and 20 oC.  Trans-2-phenylcyclopropylamine inactivated 
the enzyme with observed rates of 0.2-0.3 h-1 at 10-50 mM.  This inhibitor may not be useful to 
modify the enzyme because large concentrations of inhibitor may cause unwanted alternation of 
enzyme structure or unspecific modification.  Phenylhydrazine and tetranitromethane are better 
choices because they inactivated the enzyme with observed rate of 0.5-4.4 h-1 at 0.1-2.0 mM and 
0.1-0.4 h-1 at 0.5-5.0 mM, respectively.   
More than one modification sites may be obtained for choline oxidase when 
phenylhydrazine was used as the inhibitor, as suggested by kinetic and spectroscopic data from 
the chemical modification study.  Phenylhydrazine inactivated choline oxidase irreversibly 
because there was no activity recovered when the inactive enzyme was isolated and incubated in 
20 mM Tris-Cl at pH 8 and 20 oC.  However, when the observed rate of inactivation was plotted 
as a function of the concentration of phenylhydrazine, a second-order inactivation rate suggested 
a reversible inhibitory process.  A likely explanation for these results is that the observed rates of 
inactivation were still below the dissociation constant, KI, of choline line oxidase with 
phenylhydrazine.  The inhibitory mechanism of phenylhydrazine with choline oxidase occurred 
in the active site and involved one electron-transfer of the flavin cofactor, as suggested by the 
protective effect of glycine betaine and the formation of flavin semiquinone when the enzyme is 
incubated with phenylhydrazine at pH 8 and 15 oC in the presence of oxygen.  Nevertheless, the 
generation of flavin semiquinone was not fully responsible for the inactivation of the enzyme 
because the percentage of the enzyme with the flavin semiquinone is not equivalent to the 
percentage of activity loss.  When tryptic maps of glycine betaine-protected and unprotected 
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enzyme sample were compared, it appeared that phenylhydrazine modified enzyme at more than 
one site, i.e., more experiments are needed to improve the selectivity of the modification of 
essential residues in the active site of choline oxidase. 
Choline oxidase can be inactivated when one or more tyosines in the active site of 
choline oxidase was modified with a nitro group.  The evidence for this conclusion comes from 
the chemical modification study of choline oxidase with tetranitromethane.  In that study, 
tetranitromethane inactivated choline oxidase irreversibly.  The inactivation was both time and 
concentrations dependent.  A saturation curve was observed when the observed rates of 
inactivation were plotted as a function of tetranitromethane, indicating the inactivation followed 
first-order kinetics.  The maximal inactivation rate, kinact, was 0.32 ± 0.01 h-1, and the 
dissociation rate constant, KI, was 0.66 ± 0.04 mM.  These data suggested a reversible enzyme-
inhibitor complex and an irreversible inactivation at saturating tetranitromethane concentrations.  
This is consistent with the inactivation of the enzyme by tetranitromethane being active-site 
directed, as suggested by the protective effect of glycine betaine on choline oxidase.  UV-visible 
absorbance of both protected and unprotected enzyme sample showed the presence of nitrated 
tyrosines, but the unprotected sample had more intensity in absorbance equivalent to a difference 
of 5 tyrosines.  Although choline oxidase has 11 tyrosines total, it is unlikely that there are 5 
tyrosines present in its active site.  The tryptic maps of protected and unprotected enzyme sample 
were also compared, the results suggested that there were various modification sites and no 
specific modification site was identified with mass spectrometry.  More experiments and 
troubleshooting need to be performed in order to identify an essential tyrosyl residue, whose 
modification might be responsible for enzyme inactivation. 
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Choline oxidase can be inactivated due to a displacement of one or more protons and a 
localized conformation change in the active site, which can be induced with storage conditions.  
This conclusion is supported by the study of enzyme inactivation.  In that study, the enzyme was 
inactivated after freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at pH 
6 and -20 oC, as suggested by the complete loss of catalytic activity of the enzyme.  Comparison 
of the spectroscopic properties between the inactive and the native forms of the enzyme at pH 6 
and 15 oC showed that choline oxidase undergoes a localized conformation change upon freezing 
at pH 6 and -20 oC. Treatment at pH ≥6.5 and 25 oC can partially reactivate the enzyme, as 
suggested by the slow onset of steady state during enzymatic turnover. The conversion of 
inactive to active form of choline oxidase is a first-order rate constant that is independent of 
substrate and enzyme concentrations.  However, the rate of conversion from inactive to active 
enzyme is pH dependent, yielding a pKa value of 7.3 ± 0.1 for a group that needs to be 
unprotonated for the activation of the enzyme. The full activation of the enzyme can be observed 
spectroscopically at pH 6 and 25 oC in 3 h, with an increasing change in the absorbance at 385 
nm. A temperature-dependence study of the enzyme at pH 6 and temperatures ≥20 oC yielded an 
∆H‡ of 112 ± 7 kJ mol-1 and an entropy of activation (T∆S‡) at 25 oC of 19 ± 2 kJ mol-1. The data 
presented in this part of the study suggested that the inactivation of choline oxidase due to 
freezing at pH 6 and -20 oC involves a localized and reversible conformational change that is 
associated with a deprotonation of protein groups in the flavin microenvironment. 
In summary, the results obtained in this study showed that choline oxidase can be 
inactivated by both chemical and physical means.  Phenylhydrazine and tetranitromethane 
inactivated the enzyme irreversibly.  Both compounds are active-site directed inhibitors.  As for 
phenylhydrazine, it can be used as substrate for choline oxidase, and the inactivation with this 
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compound associated with the formation of flavin semiquinone in the presence of oxygen.  
However, the generation of flavin semiquinone is not fully responsible for enzyme inactivation.  
As for tetranitromethane, the inactivation associated with the increase in absorbance at 360 nm, 
where nitrated tyrosines absorbed.  The modification sites in both studies were not identified due 
to nonselective reactivity of the compounds on the enzymes.  Choline oxidase can also be 
inactivated by freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at pH 6 
and -20 oC.  The inactivation is reversible with pH ≥6.5 and at temperature ≥20 oC.  The results 
suggested that enzyme reactivation required a group to be unprotonated, and the ionization of 
this group induced a localized conformational change that leads to enzyme inactivation.  By 
studying enzyme inactivation due to chemical and physical means, we have gained insights into 
the biochemical properties of choline oxidase, thereby adding useful information onto the 
understanding of this enzyme, such as how enzyme function can be affected significantly by the 
modification at the active site or the displacement of a proton and a slight conformational change 
in the microenvironment of the flavin cofactor.  Consequently, the findings reported in this thesis 
may provide insights into the importance of the rigorous organization in the active site of choline 
oxidase; slight alteration of this organization can result in the complete loss of biological 
function of the enzyme. 
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